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EORTC CLASSIFICATION FOR PRIMARY CUTANEOUS LYMPHOMAS 
~...H...Km'~ E. Berti'~' S. Chjmenti1 J.L. Djaz-Per;[...MJ.. ~-~ ~ E. Ralfkiae.-"' M. Santued\Ji . .funi!hll J. Wechslc W.A. 
.Yll!!..Yl!!l£nli C J I .M. M i. 
Departments of Ocm1atology and Pathology, Free University, Amstcrdam 1, University of 
Graz2, Cha7JC Berlin\, Univcrsi~r of . ~ilan'\ Rom~~~ Bilbao6, Gen t1, Esscn1, Vienna9, 
Copenhagen , Florence , London , Pans and Utrecht 
Primary cutaneous lymphomas represent n heterogeneous group ofT and B ce ll lymphomas, 
that show considerable varintion in hi stology, phenotype and prognosis. Recently, the EORTC 
Cutaneous Lymphoma Project group has reached sensus on a new classification for this group 
of diseases (Blood, July 1997). In contrast to other classification schemes for non-Hodgkin 
lymphomas, the EORTC Class ification for Cutaneous Lymphoma is not only based on 
hi stologica l and immunophcnotypical, but also on clinical criteria. Thus, it includes a list of 
di sease entities, that have a we ll ·defined clinical presentation and clin ical behaviour. Secondary 
cutaneous lymphomas and cutaneous lymphomas arising in immunocompromiscd patients arc 
exc luded. In addition , this new class ification contains some provisional entities, which may 
disp lay typical histologic features, but are clinica l not well·dcfincd. The basic principles of this 
new class ification and the charnteristic clinical and histological features of the different disease 
entities arc presented. Based on 609 evaluable patients registered ut the Dutch Cutaneous 
Lymphoma Working Group, the frequency and estimated 5-ycar·survival data of the different 
types of cu taneous lymphomas are provided. 
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I' RIMARY AND SECONDARY CUTANEOUS CD-JO I'OSITIVE 
LYMI'HOPROLIFERATIVE DISORDERS: FOLLOW-UP AND SURVIVAL OF I 77 
PATIENTS 
F.A.M.J. Gcelco R Wil lemze 
Department of Dermatology, Free University Hosp ital, Amsterdam, The Netherlands 
Primary cutaneous CD30·positivc (anaplastic) large T-ccll lymphomas (LTCL) and 
lymphomatoid papulosis (LyP) arc closely related conditions, which arc considered to have a 
favorable prognosis. However, recent studies suggested that LyP patients have a lifc·timc risk 
of 80% to develop systemic lymphoma. Moreover, information on the prognosis of CD30+ 
lymphomas with regional lymph node involvement at presentation, and patients with a 
secondary cutaneous C0 30·posi tivc L TCL are not uvailablc. 
In the present study we therefore analyzed cl inical and fo llow·Up dnta from 177 patients with 
primary or secondary CD30·positivc lymphoproliferutive d isorders registered at the DUtch 
Cutaneous Lymphoma Working Group. This group included 96 patients (5 1 males, 45 females, 
median age 44 yrs) with LyP (group A), 63 patients (44 males, 19 females, mcdinn age 63 yrs) 
with a primary cutaneous CD30+ LTCL (group B), 8 patients (4 males, 4 fema les, median age 
66 yrs) wilh a CD30+ L TCL presenting in skin and regional lymph nodes (group C) and I 0 
patients (6 males, 4 females, median age 40 yrs) with a sceondnry cutaneous C030+ LTCL 
(group D). Five year-survival data for the different groups were as fo llows: group A: I 00%, 
group B: 92%, group C: 86%, group D: 24%. These results confirm the favornble prognosis of 
primary cutaneous LTCL. They also indicate that CD30+ L TCL presenting wi th skin and 
reg ional lymph node involvement have a similar prognosis as primary cutaneous CD30+ L TCL 
withou t regional lymph node involvement. 
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IMM UNOGLOilULIN GENE RE ARRANGEMENT ANALYSIS OF I'SEUDO II-CELL 
LYMPHOMAS IIY POLYMERASE CHAIN REACTION. 
~1• M H. Delfau' F. Mcunierl J. Wechs le.-!. B. Lcormnndi E TI10mjne' ~ ,_M, 
.lli!gQ1 nnd the French Study proup for Cutaneous Lymphoma. 
Departments of Dermatology , lmmunologl and Pathologl, Crl:teil j Departments of 
1-Iacmatolog/, Pathology:~ and Dcrmatolog/, Rauen, France. 
The diagnosis of pseudo B-ce ll lymphoma versus B·ccll lymphoma may be very difficult. 
Molecu lar ana lysis of lymphoid gene rearrangef!lCn ts by PCR is a sensitive and easy technique 
for the detection of c lOnal populations. The interest of this method in the differential diugnosis 
between pseudo B·ccll lymphomas and B·cclllymphomas has not been establ ished. We studied 
24 cases of cutaneous pseudo B·ccll lymphomas. TI1crc were 13 men and II women {mean 
agc=49 years). 111cy presented with erythematous/violaceous papules or nodules. The lesions 
were unique in 13 cases or multiple in 11 cases, localised on the head (I 0 cases), trunk ( I 0 
cases), limbs (7 case-s) and genitalia (1 case). All patients had a mixed T and B·ec ll infiltrate 
with polytypic B ·cells in immunohistology. PCR analyses were performed using consensus 
oligonucleotides 'or FR3 (oligo.sens) and FR4(oligo-antiscns) regions. Clona l rearrangement of 
immunoglobulin genes was detected in I of 24 patients. No lymphoma developed during the 9 
years of fo llow up. ln the same period we studied 20 cases of B·cel\lymphomas. 75% of these 
cases had a clona l immunoglobulin gene rearrangement. ·n1erefore, in the majority of our 
cases , PCR analysis con finned the diagnosis of pseudo B-ee!! lymphomas. In one of the 24 
patienLc;, the presence of a B-ccl l clone could be ev idenced. TI1is should not modify the 
treatment, as there were no histo logic or immunophenotypic signs of lymphoma. However, the 
possibility of late progress ion cannot be excluded and carefu l follow-up should be continued. 
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DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTE~UC CDJO+ 
LYMPliOPROLI.FERATIVE DISORDERS IS "!OT SUPPORTED BY BIOLOGICAL OAT A. 
M Bcy!ot-Barrv B Vcrgjer K Pulford P Michel J Bosq A de Muret C Bey!ot M M Qe!aunay 
M F Avril S paine C Bodemer P Joly M Bagol A de Mascarc! D Y Mnnsoo J Wechsler J.ph . 
M<ilio. 
Departments of Pathology, Histology, 'Dermatology and Statistics, CHU of Uordenux II , France; 
Department of Pathology and Molecular Science, Oxford, UK; French Study Group of Cutaneous 
Lymphoma. 
1l1e ini tial identi fication of primary cutaneous CD30+ large·cell lymphoma (LCL) with good prognosis 
from cutaneous lymphoma with extracutancous spreading is relevant for thcrnpeutic strategy. We studied 
several clinical, morphological, immunohistochemical and molecu lar features of 65 CD30+ cutaneous 
lymphoprolifcrations in statistical uni variate analysis for their prognosis significance. Primary cutaneous 
CD30+ LCL (vs systemic LCL and vs secondary CD30+ cutaneous LCL) and spontaneous regression 
were associated with a better prognosis. Extracutancous progression was unfavourable. Age (<60 years), 
loca lised or multicentric skin lesions were not found sign ificant prognostic factors. Expression of 
activation mnrkers including cpilhelia! membrane antigen, BNH9 and COtS antigens were both 
observed in primary and secondary cu taneous lymphoproliferalions. P53 oncoprotein expression was not 
associated with spontaneous regression, extracutaneous spreading or surv ival. Reverse transc iptase-
nested polymerase cha in reaction allowed the delcction of NPM·ALK transcripts in 2 out of J I 
lymphomatoid papulosis, 7 ou t of 12 primary CD30+ cutaneous LCL, I out of 3 secondary CD30+ 
cutaneous LCL and 3 out of II cutaneous and exlrncutaneous CD30+ LCL. Strikingly, an ALK·cncoded 
protein was dctcc!cd on lymphoma cells in only I out of SO prinmry cutaneous tymphoprolifcrations 
including cases with NPM-ALK transcripts. Alternatively, ALK immunoreactivity was found in 4 out of 
I 5 sceondary cutaneous LCL. 111ercforc, cells carrying the t(2;5){p23;q35) in primary cutaneous 
!ymphoprolifcrative disorders are either bystander ce lls or do not express a detectable level of ALK 
protein as opposed to ALK·positive secondary cutaneous lymphoma. However ALK immunoreactivity 
was not correlated with prognosis or age. 
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PAUAI'SOJUASIS AND EAULY CUTANEOUS T CELL LYJ\lPIJOMA 
H .G. One R. Stadler 
Ocpam1cnt of Dermatology, Hospital Minden, Minden, Gcnnany 
1l1e d iagnosis of cu taneous T cell lymphoma is based on the clinical picture, the course of the 
disease and histo logical examinations. Immunohistochemistry can help to d ifferentiate tumour 
cells and can give further information about the expression of antigens on the surface of the 
tumour ce ll s with some prognostic impact, i.e. CD30 ex. pression. T cell receptor rearrangement 
studies arc an additiona l diagnostic hint of cutaneous T cell lymphoma but no prove of 
malignancy. 
Early cutaneous T cell lymphoma have to be separated from diseases of the parasoriasis group, 
like parapsoriasis en plaques and lymphomatoid papulosis. However, for some diseases of the 
parapsoriasis group the proceeding to cutaneous T cell lymphoma is discussed. Therefore 
differCntia\ diagnosis between these fonns and early cutaneous T cell lymphoma is often 
difficult and will be demonstra ted according to se lected cases from the Department of 
Dermatology Minden. 
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PROGNOSTIC SIGNIFICANCE OF A PCR-DETECTADLE DOMINANT T-
LYMPHOCYTE CLONE IN CUTANEOUS LESIONS OF PATIENTS WITU MYCOSIS 
FUNGOrDES. 
M.H . Dclfnu-Lame1.S . Dalac~ E. Lepage" T.Pcttclhl' J Wechsler~~· 
Departments of Immunology, Statistics3 , Patholgy , Dermatolg/ Crc teil j Departments of 
Dcmlutolgy2, Pathology" Dijon, France 
Allhough mycosis fungoides (MF) is considered to be an indolent lymphoma, survival is highly 
influenced by TNM stage. At diagnosis, most MF patients present with early stage disease and 
a high probability of long term survival. Treatment is generally directed towards skin lesion 
and ach ievement and duration of complete responses arc variable. A dominant T·ce ll clone is 
detectable in the cutaneous lesions of 60% of patients. The aim of this study was to determine 
whelher the presence of a T-ccll clonal population influences the clinical response to treatment. 
Cutaneous biopsies from 71 patients were histologically d iagnosed as MF and T·ccll elonality 
was ana lyzed by in vitro amplification of TCR-gamma chain gene rearrangement 
(PCRgammu). After a median follow· up of 27 months response to treatment (complete or not) 
was clinically assessed. Age, sex., duration of symptoms before diagnosis, type of cutaneous 
lesions {T s tage) , TNM stage, and PCRgamma were evaluated as predictive factors of response 
to treatment in univariate and multivariate ana lysis. Univariate analysis pcm1itted to 
demonstra te the positive inOucncc ofT stage (p< IO"\ overall TNM stage (p=0.031) and PCR 
gamma (p=0.026) on treatment response. Using a multivariate acya lyscs, T stage (relative risk of 
15 .8) and PCRgamma (re lative risk of 5.5) remained the two independent s ignificant predictive 
parameters of response. In conclusion, T stage Und cutaneous PCRgomma at diagnosis nrc the 
two predictive parameters of treatment response fo r MF. This is the ftrst evidence of the 
necessity of considering PCRgamma results in therapeutic protocols. 
VOL. 109, NO.3 SEPTEMBER 1997 
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LYMI'HOCYTE REI'ERTOlRE STUDY BY PCR-DGGE IN CUTANEOUS 
LYMPHOCYTIC INFILTRATES. 
M. D'lncan1. J.P. Bounol C. Picard1 Y.J. Bignon.! P. DCchclottc1\ P. Soutevrnnd1 
Dcmatology1 and Pathol~gy2 Departments, Molecular Oncology , Laboratory INSERM-Cn.J 
9402, ClCrmont-Fcrr:md, France 
Our aim was to study the clonal repertoire in cutaneous lymphocytic infiltrates of benign and 
malignant orig in . 
Method. T-ccll receptor gamma chain gene rcarnmgcmcnts were studied by monoplcx PCR-
CG-Ciamp DGGE (lymphocy tic repertoire study) and multiplex PCR (to detect dominant 
lymphocytic clones) in 43 cutaneous and nodal biopsies from : 16 mycosis fungoidcs (MF) or 
SCzary syndromes (SS), 13 pleiomorphic lymphomas-CDJO+ (PL), 6 lymphomatoid papulosis 
(LyP), 5 non cu taneous T-ccll lymphomas (NCTCL) and 3 cutaneous pscudolymphornas. 
Twelve cutaneous samples were obtained from: I Hogdkin' s disensc and II benign 
lymphocytic dennatoscs. 
Results. One or two dominam clones were detected in 69% ofMf and SS (0% at early stages of 
the disease, 100% at late stages), 91 % of PL, 17% of LyP, SO% ofNCTCL and 0% of other 
cases. Two dominant rearrangements were detected in 92%, 27% and 0% of PL, MF and LyP 
respecti vely. Lymphocytic reperto ire study revealed the same clone compound in non 
simuiLaneously appearing lesions of LyP nnd PL lesions in another pntient. 
Comments. TI1is study: 1)- confinns that TCR Sll.1dics cannot discriminate between benign 
lymphocytic infiltrates and lymphomas at early stages, 2)- suggests tlmt PL have u particular 
genotyping pattem, 3)- suggests, in case of LyP and PL, the existence of a ce llular immune 
response uga inst the dominant clone is conserved in success ive lesions. 
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IMM UNOI'HENOTYPIC AND GENOTYPIC ANALYSIS OF THE CUTANEOUS 
LYMPHOI.D INFILTRATE IN ANGIOIJ"LMUNOBLASTIC LYMPHADENOPATHY. 
P. Joly M. Bagot L. L:1roche C. Bodcmcr E. Thominc S. Fraytng n. Lcommnd M.H. 
Delfau J. Wechsler French Study Group on Cutaneous Lymphom~s. 
111c aim of this study w:1s to analyse the immunohistological picture and the T-cell receptor 
(TCR) gene arrangement in skin biopsy specimens from 7 patients with angioinununoblastic 
lymphadenopathy (AIL). Skin samples were characterised immunohistologica lly by sta ining of 
cryostat sec tions with a p:1nel or monoclonal antibodies. "l11c T-ccll receptor y ch::tin gene 
rcnmmgcmcnt was studied in skin samples using the PCR-DGGE technique. Seven p:1ticnts (5 
fcm:llcs, 2 nmlcs) were included. Six patients presented transient and recurrent skin cmptions, 
whereas the lnst patient hnd papulonodular cutaneous lesions. A poor perivascular infihrate 
composed or small lymphoid cells with a 111aturc T-ccll phenotype was observed in 4 cases. In 
the 3 other cases, a dense lymphoid infiltrate composed of medium and large pleomorphic T-
cel\s was observed. Loss of one or serveral pan-T cell anti!Jens (C02. CD3. CDS. CD7) was 
obse rved in the 3 cases. t\ monoclonal reaJTangement of the y chnin of the TCR was observed 
in 4 of 7 cases including 2 cases correspondending histologicnlly to a pleomorphic T-cell 
lymphoma nnd 2 cases with a "non specific" immunohistological picture. indicating thnt 
transient skin eruptions may correspond to a specific Joco\izntion of the lymphoma in patients 
with AlL 
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OIUG!N OF C IRCULATING CLONALT CELLS IN I'ARA I'SOIUASIS EN I'LAQUES 
(I'EP) -IS THERE A RELATION TO CUTANEOUS T CELL LYMI'HOMA (CTCL)"! 
M. Muchc A. Lukowsky S. Richter U. Hciduk W. Sterry 
Department ofDem1:1tology, Medical Fucuhy CharitC, Humboldt University Berlin, Gcm1uny 
PEP is defined by ov:1 l plaques with atrophy and a fine sca ling, located mainly on the flank side 
of the trunk. l11e histologica l pattern is characterized by an unspecific band-like 
lymphohis tiocytic infiltrate in the upper demtis. Recently, some evidence wos round that PEP is 
n precursor ofCTCL. To cvaruatc !his, we invcsrigarcd the occurrence ofclona!ly exp:1ndcd T 
cells in skin and blood samples of 14 PEP patients by TCRy PCR in combina tion with 
temperature gradient gel electrophoresis. The specificity of our approach was confim1ed by the 
non-detection of clonnl T cc\l s in 60 blood specimens obtuincd rrom psoriasis vulgaris, atopic 
dcnnatitis rmd healthy volunteers . In PEP, monoclonal T cells were detected in 8/14 blood 
samples and none of the skin specimens. The resuhs were confi rmed by sequencing all the 
dominant TCRy rcnrrungcments found. For the first time, these data demonstrate n high 
frequency of flEP patients with clonall y expanded T cell s in their peripheral blood. TI1is1 in 
tum, strongly suggests a n:lntionship between PEP and T cell lymphoma. However, by the 
technique app lied monoclonal T cells were not found in skin lesions of PEP. Clone specific 
PCR assays and DNA probes will be developed on base of the dominant TCRy sequences of 
the peripheral T cells . ·n1cse techniques should enhance the sensitivity in order to find the 
cxpnnded T ce ll clone also in the corresponding skin specimens. 
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CLONAL EVOLUTION STUDfED BY SINGLE CELL ANALYSIS IN A PATIENT 
WITH A I'IUMARY CUTANEOUS FOLLICULAR CENTER B CELL LYMPHOMA. 
S Golembowski S. Gel\rich S. Lippert M. von Zimmcnnann S. Jnhn W Steny 
Department or Dermatology. Medical Faculty (Charitc), Humboldt-University Berlin, FRG. 
Micromanipulation from tissue sections and s ingle cell PCR is un elegant method to study 
cutuneous B-ccl l lymphomas. In one patient , in 1994, a primary cutaneous B cell lymphoma of 
the follicular center cell type (centroblastic/centrocytic) was diagnosed with no systemic 
involvement detectab le. From a tota l of 11 single 8 cells the rearranged Vl-lDJH gene was 
amplified showing the mutational pattern of antigen-driven clonal B cell expansion. There was 
no intraclonal diversity detectable. However. the analysis of a biopsy obtained in 1996 in 
comparison to the previously studied sample showed ongoing mutations in the VH gene 
(however again no intraelonal diversity). In 1997 :1 retroorbitnl tumor was analysed showing 
the features of a B cell lymphoma. Single cell analysis again documented the expansion of the 
malignant clone, however soma tic mutations were sti ll ongoing. To characterise the mutational 
process in the VH gene in more detail, the individua l gem1linc counterpart was cloned from 
patient's DNA . Furthermore the kappa light chain gene reammgcmcnls were dcrceled in singJe 
cells and sequenced showing somatic mutations comparable to VH genes. Both VHDJH and 
VUL gene renrrangements were amplified from eDNA obtained from skin biopsy materiaL 
This confim1s that the respec tive genes exist as transcripts. 
ll1e interesting findin g is, however, lhnt the analysis of on ly one biopsy showed no intrnclonal 
diversity suggesting a post-gcnninal center cell lymphoma. Only when different biopsies where 
analysed the process of ongoing somatic mutations became evident which is typically found in 
germinal center cel l lymphomas which still grow under T cell help inOucnced by antigen. 
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DETECriON OF MALIGNANT T CELL CLONES IN MYCOSIS FUNGO!DES BY 
I'CR ASSAYS OF TCHf GENE REARRANGEMENTS 
A. Lukowsky M. Muche U. Heiduk S. Richter W. Sterry 
Department of Dcnnatology, Medical Faculty CharitC, Humbold University Berlin, Gcnnany 
It is well established that f\ff. is n clonal expansion or T cells carrying identical copies of 
rearranged TCR genes. Tiu;:reforc, the demonstration o f a dominant T cc\1 clone in cutaneous 
infiltrates confinns the diagnosis additionally to clin ica l, hi stopathological and 
immunophcnotypic criteria. In roi1tine d iagnosis we invcstignte the occurrence of monoclonal 
T cells in skin biopsy samples of patients with suspected or established MF by applying 
severa l TCRy PCR nss:1ys toget her with the heteroduplcx temperature gradient gel 
electrophoresis. For :t 2 years period, from all patients studied in ur laboratory , MF was found 
in 208 cases following histopa thology nnd clinica l criteria. From 188 of these MP patients, at 
le;1sl one ~kin sample of sufficient DNA quality enabling the PCR assays, were obtained. 
Applying a PCR with consensus primer for the most frequently rc:\rronged TCRy genes Vy I 
and Jy 112. we deteted expanded T cell clones in 122 cases (65%). ln the remaining 68 cases, 
we pcrronl\cd two multiplex PCR, covering rcarragemcnts of all other TC Ry genes, except Jy 
P. Hereby we found in II cases (6%) predominanl clona l reammgemcnts of Vy n - IV and 
Jy \/ 2 and in 2 cases (I %) those ofVy I-IV and Jy Pl /2. TI1c dnta show the rare Us:\gc of the 
Vyii-JV and, p<lrticulnr, Jy P J/2 in TCRy gene rcammgemcnrs in MF. TilCreforc, PCR defecting 
only rearrangements of Vy I and Jy l/2 arc sufficiently in screening analysis for clona\ity in 
MF. ln a fraction of 28% or our MF cases the applied PCR techn iques fai led to demonstrntc 
monoclona l T ce lls, poss ibly due to their low amount or chromosomal abbcrations. 
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SEQUENTIAL ANALYSIS OFT-CELL RECEPTOR GENE REARRANGEMENT IN 
SKIN BIOPSY SPECIMENS FROM 6 PATIENTS WITH HODGKIN DISEASE, 
LYMPHOMATOID PAI'ULOSIS, MYCOSIS FUNGOLDES AND CD30+ LARGE CELL 
LYMPHOMA. 
P. Jo ly 13. Lcnormnnd M Bagot P. Soutcvmnd M.-H Dclfnu F TI10minc and J Wechsler. 
French Study Group on Cutaneous Lymnhomas. 
T-cell receptor gene rearrangement was studied using PCR·DGGE in skin and nodal frozen 
samples from 6 patients who experienced scquen tittlly during if ten year· fol low-up period 2 or 
more of the following diseases: Hodgkin disease, lymphatoid papulosis, mycosis fungoidcs 
(MF), nodnl or cutaneous CD30+ large celllymphomu (LCL). 
A monoclonal rcaiTangemcnt of the TCR y gene was observed in 3 of 3 biopsies o f 
lymphom:ltoid papulosis, in 4 of 5 M.F skin biopsies. in one MF dcnnatopathic 
lymphadenopathy, in 5 of 5 skin biopsies of cuwneous CD30+ LCL nod 2 of 2 lymph nodes 
from nodal CD30+ LCL. On ly one adenopathy from n patient with Hodgkin disease was 
~tvailnblc, with no detectable TCR y gene renrTnngcmcnt. A comigration of the DNA extracted 
from the different skin or noda l biopsy !;pecimcns was observed in each of the 6 patients. l11cse 
results suggest that a common lymphoid cell progenitor leads to various lymphoproliferativc 
CD30+ disorders iJJ these paricnts. 
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THE llrl2 SIGNAL TRANSDUCTION PATHWAY IS DEFECTIVE IN 
MALIGNANT T-CELLS IN SEZARY SYNDROME 
FE Fox Z Niu DMF Kao AH Rook 
University of Pennsylvania, Philadelphia, PA 
Sczo.ry syndrome (SS) is the leukemic phase of cutaneous T-cell lymphoma and is 
characterized by the proliferation of clonally-derived CD4+ T-cells which release cytokines of 
the Th2 T-cell phenotype (IL-4, 5, I 0). Moreover, production of Th I cytokines (!L-2, IFN 
gamma) by peripheral blood lymphocytes (PBL) in SS is markedly depressed. Since responses 
to IL-12 are 
critical for nonnal Th l differentiation, we examined the IL-12 signal transduction pathways 
(Jak 2/Stat 4) in normal and malignant T-cells from SS patients and in PBL from normal 
controls. Lymphocytes were activated with PHA for 3 days , cultured in low serum containing 
medium for 24 hours then stimulated with IL-12 for 15 min, prior to lysis and 
im.munoprecipitntion. Using anti-Stat 4 and anti-phosphotyrosine antibodies, Western blot 
studies indicated , in purified malignant T-cells, the presence of Stat 4 protein which failed to 
become phosphorylated in the presence of IL-12. in contrast, Stat 4 became phosphorylated in 
non-malignant T-cells from SS patients and normals when stimulated with IL- 12. Similarly, Jak 
2 failed to become phosphorylated in malignant T-ccll s in the presence oflL-12. These studies 
suggest that a proximal defect in JL - 12 s ignaling exists in the malignant CD4+ T-cclls which 
may include the failure to eltpress high affinity receptors for IL-12, which is currently under 
investigation. This profile. including the absence of high affinity TL-12 receptors and lack of 
phosphorylation of IL-12 responsive Jak/Stat components is typical of Th2 helper T-cells. 
TI1cse results further support our previous observations that SS is typified by a proliferation of 
Th2 cells. 
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HUMAN HERPES VIRUS-8 SI'ECIFIC DNA SEQUENCES IN PIUMARY CUT AN EO US 8 -
CELL LYMPHOMAS. 
I Cerronj N Zfichljng P Wolf B Piltz H Kcrl Dcpl. ofDem1atology, UniversityofGraz, Austria. 
Human Herpes-virus-8 (HHV-8) has been identified in Kaposi's sarcoma as well as in various forms of 
exl.r.lcutaneous lymphoprolifcrativc disorders in patients with or without HJV infection. In five cases of 
cu taneous B-cclllymphoma (CBCL) tested so far, the presence of HHV-8 could not be demonstrated. 
We investigated formalin-fixed, paraffin-embedded biopsy specirns from 50 patients wi th primary CBCL 
for the presence of HHV-8 using a nested PCR-tcehnique followed by Southern blot hybridisntion. 
Details on primers have been published. In all cases monoclonality of the B-cell infiltrate was confirmed 
by immunohistologic pattern of immunoglobulin light chains and I or PCR analysis of lgH gene 
rearrangement Only patients with primary CBCL were involved (os defined by disease localised solely 
to the skin for 6 months after complete staging procedures). None of the patjents included in this study 
had ArDS or Kaposi' s sarcoma, but the HIV serostatus is not known. 
The nested PCR technique was as follows: in the first step, a 233bp product was amplified using the 
KS330m primers. In the second step an additional interna l 169bp fragment was amplified using primers 
NS I and NS2. The ll-actin gene was successfully amplified in all cases. Specificity of PCR products was 
confim1ed by P12 Southern blot hybrization using a 25 base-pair internal ol igonucleotide probe as 
described previously. Five positive (AIDS-associated Kaposi's sarcoma) and five negative controls 
(heallhy skin 2, lichen rubcr I, psoriasis I, normal tonsil tissue I) gave resu lts as expected. HHV-8 
specific gene sequences were identified in 3/20 follicle center cell lymphomas, 3/20 marginal zone B-ccll 
lymphomas, 1/20 large cell B-celllymphoma, and 0/4 immunocytomas. 
Our results demonstrate the presence of HHV-8 DNA sequences in a percentage of patients with various 
types of CBCL, suggesting a possible involvement of this lymphotropic virus in the pathogenesis of at 
least some of these cases. In fact, the presence of a functional, constitutively active G-protein-couplcd 
receptor, recently demonstrated in HHV-8, could lead to altered growth and I or neoplastic 
transformation. The low percentage of HHV-8 positivity may explain why no positive cases cou ld be 
identified in the small series published by Sander et al. 
Further studies are necessary to evaluate the role of this vims in the pathogenesis of cutaneous 
lymphoproliferattvc diseases. 
17 
SEZARY SYNDROME'S (SS) T-CELLS ARE DEFICIENT IN INTERFERON SIGNALLING 
DESI' ITE OVEREXPRESSION OF INTERFERON RECEI'TORS. 
R Dymmcr U P 8bbeling S Hemmj J Pqv!ov jc J -Z Ojn E I ajne R Gecrtsen G Byn• 
Departments of Dermatology, Mcd. Virology, Molecular Biology, Zurich University Scbool of 
Medicine, Zil rich, Switzerland. 
SS is characterized by a clona l accumulation of ITUI!ignant T-lymphocytes in the skin and in the 
peripheral blood. Using antibodies against the variable region of the T-ccll receptor (TCR) or CD4/CD7 
double stainings, the predominant T-cell clones in SS can be purified. 
These clona l ce lls secrete l11-2 cytokines (IL-5, -10,-13) and ovcrexprcss intcrfcron-y receptors. ln this 
study we assess express ion levels and signa ling through IFN-a or [fi'N-y receptors in PBMC of SS 
patients. From three SS patients clonal CD4t, CDT T-cells were sorted and analyzed for express ion of 
IFN-y R- II -2, HLA-1, HLA~ll and ICAM- 1 in presence or in absence of lFN-a. or IFN-y by flow 
cytometry. Functionality of IFN-a. R- t/-2 was tested by screening for uprcgulotion of MxA in 
immunofluorescence assays. Band shift and super shift experiments were performed to analy.tc IFN-y 
dependent signa l transduction by STAT- t/-2 factors (signal transducers and activators of transcription). 
A 10-100 fold upregulation ofiFN-y R-2 was observed in all three samples compared to hea lthy control 
PDMC, for IFN-y R- t the effect was less drastic but still sign ificant. No response to stimulat ion wilh 
lfN-y was observed, all cell-surface markers remained unchanged with regard to expression levels. In 
contrast', all contro ls showed significant upregulation of HLA-t, HLA-lf and ICAM-1 afier stimulation. 
Band shift experiments revealed consti1t1tive binding of STAT factors, that was not incrcosed by IFN-y. 
Looking at expression of HLA-1 and MllA molecules the lFN-a signaling pathway was unaltered for one 
patient, slightly reduced for the second and completely blocked for the third patient. Again, nil controls 
showed normal response to stimulation with lFN-a. Our data show a constant deficiency of SS ce lls in 
IFN-y signaling despite ovcrexpress ion of the receptor and heterogeneous defects in JFN-a signaling. A 
precise evaluation of the pathogenesis of SS may help to identify possible targets for molecular 
interventions in these diseases. 
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IDIOTYPE PEI'TIDES FOR IMMUNOTHERAPY OF CUTANEOUS T CELL 
LYMPHOMAS 
C. Brock A. Mielke A Lukowskv M Muche K.-H WjesmUller• G Jung• W Sterrv and P. 
Walden 
Department of Dermatology, Medical Faculty CharitC, Humboldt Univers ity, Berlin; •Naturol 
and Medical Sciences Institute at the University ofTUbingen in Reutlingen; Germany 
In cases of lymphoid cancers the idiotypes of the malignant cells' immune receptors nrc ideal 
tumour antigens well suited for both, unequivocal identification of the ma lignant c lone and 
design of vaccines for cancer immunotherapy. We have sequenced the gene section coding for 
the CDR3 region of the J3 and y TCR chain, and arc planning the same for the Ct chain. The 
junctional region was amplified by PCR using consensus and/or family specific primers. The 
PCR product of the malignant clone was identified and isolated using temperature gradient gel 
electrophoresis and then sequenced either directly or following AT cloning. Libraries of 
overlapping peptides were designed according to the corresponding amino acid sequences and 
tested for their capacity to induce idiotype-spcc ific response by cytotoxic T lymphocytes 
isolated from peripheral blood of the patients. The spccifity of the reacting cells can then be 
confirmed in ce ll mediated lympholysis assays. Pcptides identified this way to be antigenic in 
cutaneous lymphoma patients can then be used - in combination with suitable adjuvants - as 
vaccines to induce tumour spec ific cytotoxic T cell responses in the patients and might be 
applicable for immunotherapy of these malignancies. 
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INTERFERON ALPHA INCREASES EXPRESSION OF AN EBSTEIN-BARR VffiUS 
LATENCY TRANSCRil'T (EBER) IN KERA TrNOCYTES. 
0 Jumbou I. Tcnaud I Sainte Marie B. DrCno. 
Department of Dermatology, Hotei-Dieu, Nantes, France 
Interferon alpha may increase transcriptional expression of EBER which is an early RNAs of 
Ebstein-Barr Virus (EBV) actively transcripted in latency infected monocytcs. We decided to 
applicate this phenomena to amplify the detection ofEBV in kcratinocytes both in vitro and in 
vivo. Indeed kerainocytc might be another site of infection of EBV in addition of B 
lymphocytes but the pcrcenlagc of infected cells is very low. 
For in vitro study, a mixed culture with EBV B 95-8 cells and normal keratinocytes has been 
performed for 7 days with or without interferon alpha (1500 TU). EBER was detected by in s itu 
hybridisation. For in vivo study, 61 skin lesions of cutaneous T cell lymphoma (CTCL) in 
which EBV could play a role were studies for EBER expression by in situ hybridisation either 
without (28 skins) or aficr treatment (33 skins) with interferon alpha (6 106 IU for 3 or 4 
month). 
In vitro, on ly 1% kcrntinocytcs expressed EBER without interferon alpha in medium, but 12% 
with the addition of interferon alpha. In vivo, 11 /33 epidermis o fCTC L after interferon alpha 
therapy were EBER+ and only 4/28 epidermis without treatment (p<O.OS). 
So our study shows that interferon alpha increases EBER expression in kcmtinocytc and 
confirms the presence of EBV in keratinocytcs of CTCL where it may play a role by 
modulating the activation of kerntinocytes and so the interaction keratinocyte-lymphocytc. 
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TYI'E I I TYPE 2 CYTOKINE EXPRESSION DURING I'ROGRESSION OF MYCOSIS 
FUNGO IDES. 
K Asadullah W.D. D5ckc M Friedrich A. HaeuOicr H D. Yolk W. Stem 
Departs. of Dermatology and Immunology, University Hospital CharitC, Berlin, Germany. 
Cytokincs nrc believed to play an important role in the pathogenes is of cutaneous T ce ll 
lymphoma. Data regard ing the local cytokinc pattern in mycosis fungoides(MF) nrc partly 
conflicting. Recent studies have suggested a shift from type l to type 2 cytokinc pattern 
because interleukin (IL)~4 and JL-5 mRNA, have been more frequently detected in lesions of 
advanced stages. Another study has described a type I cytokine pattern in MF lesions. 
However, none of lhe studies of cytokine mRNA expression in MF carried out previously used 
quantitative methods and therefore only the presence of a cytokinc could be determined but not 
the level of expression. To gain better insight into the development of cytokine pattern during 
tumor progression we used semiquantitative RT-PCR to analyze cytokine mRNA expression in 
MF skin les ions at different stages. Biopsies from patients with patch (n=l l ), plaque (n=6}, and 
tumor (n=3) stage MF were compared to biopsies from patients with pleomorphic T cell 
lymphoma (n=5), psoriasis (n=7), atopic dermatitis (n=S), and healthy skin (n=8). MF 
progress ion was associated with significantly higher IL-10 and lower interferon gamma m.RNA 
expression. Moreover, the stage-dependent increase ofiL-10 mRNA expression was also found 
in paired samples from individual patients. However, unlike in pleomorphic T cell lymphoma, 
typical Th2 cells did not seem to be the source of increas ing IL~ I 0 expression in advanced MF 
s ince stage-independent lL-4 mRNA was rarely detected, suggesting contribution of non-
lymphoid cells in loca l lL-10 production. The overexprcssion of IL-10 in MF may be of 
importance for tumor progression since this immunosuppressive cytokine might be involved in 
downrcgulation of immunological tumor survei llance. 
VOL. 109, NO.3 SEPTEMBER 1997 
19 
ABSENCE OF TH2 CYTOKJNES IN I'RlMARY CUTANEOUS CD30-NEGATIVE 
DIFFUSE LARGE T CELL LYMPHOMAS 
M.H. Vermeer C.P. Tenscn P.M. van der Stoop J.H . van Oostvecn M. Lund K. Thcstrup-
Pcdersen R. Wi ll emzc 
Departments of Dermatology and Pathology, Free University Hospital , Amsterdam, The 
Netherlands; Department of Dermatology, Murseli sborg Hospital, Aarhus, Denmark 
Recent studies demonstrating that the neoplastic cells in SCzary syndrome (SS) and tumor stage 
mycosis fungo ides (MF) express lL-4, rL-5 and IL-l 0, have resulted in the concept that 
cutaneous T cell lymphoma (CI'CL) arc derived from CD4+ Tit2-cclls. TI1e predominance of 
IL-2 and lFNy mRNA in early MF lesions was attributed to reactive tumor-infiltrating T ce lls, 
and led to the concept that CTCL patients might benefit from therapies that augment "1111 
responses. 
In the present s tudy 4 primary cutaneous CD30·negative large T cell lymphomas (PCL TCL) 
were studied for the expression of Th I and 1112 cytokincs using a reversc-transcriptasc PCR 
technique. 
ln contro l biopsies lL-2 and IFNy was consistently found in nom1al skin (n=3), lichen planus 
(n~2), psoriasis n~5) and plaque stage MF (n~J) , whereas expression of IL-4 and IL-5 was 
limited to tumor stage MF (n==2) and SS (n=3). In the 4 PCLTCL showing an almost pure 
popu lation of large tumor ce ll s (>90%) no expression of IL-4 was found, whereas JL-5 was 
found in only 1 of 4 cases. TI1c absence of IL-4 and fL-5 mRNA in these cases was eon finned 
on additional biopsies taken nt the same lime or during progression of disease. The absence of 
1112 cytokinc mRNA in these PCLTCL suggests that tumor cel l growth in these lymphomas has 
become independent of growth-regulatory cytokincs in the local skin environment, which may 
explain their aggressive clinica l behaviour. 
21 
GENETIC MARKERS ASSOCIATED WITH MYCOSIS FUNGOIDES 
V. Brazzclli F. Baldini F. Borghini M.R. Gaviglio A. Pasi: M. Martinelli: L. Sa!va.ncsehi:.,. 
G. Borroni. 
Department of Human and Hereditary Pathology, Institute of Dcnnatology and 
lmmunohacmatolgy", University of _Pavia, Policlinico S. Matteo, IRCCS PAVIA ITALY. 
Mycosis Fungoides (MF) is a low·gradc cutaneous T-cel\ lymphoma of unknown aetiology, 
which starts in the skin and may remain confined to the skin for several years, and which , in 
later phases, can also affect lymph nodes and internal organs, taking a le tha! course. Disease 
can run from years to decades before changing its morpho logical and immunohistochemica l 
characteristics into those of high grade T-celllymphoma. 
Since environmental causes as well as immunological and viral factors have been suggested in 
MF, HLA assoc iated variations in genetic susceptibility are likely to piny a role in the 
pathogenesis ofMJ7 
HL A class .I and U serologica l typing was perfonncd in 32 MF pntienlS and 179 ethnically-
matched controls. H"LA-B35 gene frequency was significantly increased in Mli with respect to 
the controls (3 1,25% vs 13,96%; p~0,00047 ; RR~2, 85). In particular, the HLA -A24,CW4, 
8 35, DRll , DQ7 halotypc was significantly more frequent in patients than in unaffec ted 
people (9,37% vs 1,67%; p=0,00 12; RR=5,59%).111e HLA 8. 1 ancestral haplotype was absent 
in male patients, while wns present in 13,64% of females (p=O,O 14). 1-lLA-DR 13 alle le seemed 
to correlate with the early-onset fonn of the disease (2 1,43% vs 2,0%; p=0,0079; RR=-13,36). 
Far from any conclusion, the s tudy s imply suggests 10 further invcsHgate in this direction 
principally because MF is clinically heterogeneous and aetiologico lly still obscure. 
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COMPARATIVE GENOMIC HYDRIDISATION DETECTS GENETIC CHANGES IN 
SEZAJ!Y SYNDilOME. 
L. Knrenko1. M. Ktihktinen1 E. Hyytinen! A RankiL.i 
1
'
4Dcpartment of Dennatology, Helsinki Un iversity Central Hospita l, Helsinki, 2Dcpnrtrnent of 
C linical Genetics , 1Labora tory for Cancer Genetics and 4Department of Dcnnatolgy, Tampee 
Univers ity 1-Iospital, Tamprc, Finland 
Changes in DNA-copy number in blood lymphocytes of 4 patients with mycosis fungoides and 
7 patients with SCzary syndrome were studied with comparative genomic hybridisa tion (CGI-1), 
which detects losses and gains of DNA-sequencics and loca lises them in their respective 
chromosomal regions. The sensitivity of CGH for amplified DNA is about 2MB (5- to 7-fold 
amplifications of oncogenes) and for deletions 10-20MB. 
Five of 7 patients with SCzary syndrome had losses or gains affecting 1-9 chromosomes. 
Losses were more frequent than gains, and concerned mostly whole chromosomes or am1s. 
Three patients hod a combination of loss of 2p and 10 q, and two of them had also gain o f Sq. 
These three changes were also observed in one follow-up sample taken 4 months after the first 
sample, und confim1cd by in situ hybridisations with specific painting probes when ce lls were 
available (2 patients). These regions arc likely to be important in the molecular pathogenes is of 
SCznry syndrome. Many other, more sporadic changes in CGH were also confinned by in situ 
hybridisations in several patients. CGI-l requires at least about 50% of similarly aberrant cells, 




HJSTOLOGICAL AND IMMUNOHJSTOCHEMICAL COMPARSION BETWEEN 
MYCOSIS FUNGOIDES AND SEZARY SYNDROME 
J. Knmarashcv G. Burg R. Dummer 
Department ofDcnnatolgy, University Hospital ZOrich, Switzerland 
Mycosis fungoides (MF) and SCznrys syndrome (SS) arc close ly related cutaneous T- cell 
lymphomas, which differ in the aspect o f peripheral blood involvement We studied and 
compared histological and immunophenotypieal features of these two entities, which could be 
implicated in the dem1otropism, charnctcristic for both of them. Titirteen biopsy specimen from 
patients with established MF and 13 from SS patients were examined retroperspccti vely and 2 1 
histological criteria, among which acanthosis, spongios is, hypcrccratosis, type of 
epidem1otropism (Pautrier collections, lining a1 the dcnno-cpidermal junction, single cell 
cxocytosis or pagetoid infiltration), composition of the infi ltrate, fo llicul ar mucinosis, oedema, 
scleros is and venule proliferation, were assessed . Further, 9 cryoscetions from MF and SS 
lesions each, were stained for ICAMI , LFAI , CD40, CD40-Iigant, FAS and FAS-Iiganl. The 
only histological criteria that showed any significant diffe rences were acanthosis (in 12 of 13 SS 
and 7 of 13 MF specimen) and Pautricr collections (detected in 6 SS and II MF biopsies) . 
Patterns of staining with the antibodies mentioned above, were also similar. LF A was positive 
on lymphocytes and JCAMI stained both epidermis and lymphocytes. CD40, CD40-ligand and 
FAS were positive and after quantitati ve evaluation no s ignificant difference could be detected 
between MF and SS specimen. F AS-Ii gant was negative. Our results indicate that these 
interaction molecules nrc probably involved in the pathogenesis of MF and SS, but their 
immunohistochemical distribution docs not contribute to the differentiation between the two 
entities. 
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CDKN2AIP16 EXPRESSION lN MYCOSIS FUNGOIDES 
MC fprgoo tjl~l_._Q. •• S1il.nl.!!.l.~l~~...A...E£.lli!~l 
1 Department of Dennatology, University of L 'Aquila, ltnly; 2 Department of Pathology-University of 
Trieste and lntcmacional Center of Genetic Engineering and Biotcchnology-Padriciano, Trieste, Zlnly; J 
lstituto San Gallicano, IRCCS, Rome, Italy. 
llte CDKN2A gene encodes a protein, named p16, that plays a key rol e in cell cycle control by binding 
to CDK4 and CDK6 enzymes and inhibiting their ability to phosphorylate critical substrates necessary 
for transition through the 0 1 phase of the cell cycle. Mutations or deletions of the CDKN2A gene result 
in unchecked celt prolifernt ion fo r n defective cell cycle control. Recent reports have suggested that 
CDKNZA may play a major role in either the development or progression of a variery of human cancers. 
To verify if altered CDKN2A expression is involved in the pathogenesis of cutaneous malignant 
lymphomas, total RNA was extracted from formalin fixed, paraffin-embedded tissue sections of 20 
mycos is fungoides, reverse transcribed and amplified by JloJymerasc Chain Reaction. Amplified 
products were tested by dot blot hybridizat ion using a n P-ATP labeled intemal oligonucleotide probe 
and the single spots were measured in n P-counter. Three different levels of CDKN2A mRNA expression 
~verc detected: Ieve ii (0 cpm) in five eases, level ll (0-500 cpm) in 13 patients nnd lcvcl lll (>500 cpm) 
Ill two cases. Two representative cases of each group were screened for p 16 protein express ion by 
inununohistochemistry using monoclonal and polyclonal a pl 6 antibodies with either APAAP or 
inununoperoxidasc technique on fonnalin fixed, paraffin-embedded tissue sections. p 16 protein 
expression was undetectable in 2 cases (less than l% of the neoplastic lymphocytes were stained) which 
showed no CDKN2A mRNA cxprc:ssion, low (range l%-25%) in 2 cases with intermediate mRNA level 
and high (>25% posi tive neoplastic ce ll s) in 2 cases with very high levels ofCDKN2A mRN A transcript. 
Thercfo(e, the inmmnohi stochcmica\ results perfectly e;orrclated with molecular analys is of CDKN2A 
mRNA expression. The weak or absent CDKN2A mRNA and protein expression. as detected in most 
MI; examined, might be related to dclel'ion or mutation of the CDKN2A gene. High CDKN2A mRNA 
levels and high pl6 express ion were found in 2 of 20 cases and seem to be associated with a slower 
progression of the disease. 
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HOXC4, -CS AND --C6 EXPRESSION IN PRIMARY CUTANEOUS LYMPHOID LESIONS' 
HIGH EXPRESSION OF HOXCS lN ANAPLASTIC LARGE CELL LYM_l)I-IOMAS 
C J! M Mejjer'-....1J....lliil1~ JW yan Oostvcen! JMM \Vn\boomcrs1~1~ 
~!. 
Departments ofPntltology1, Hemato\og/und Dcm1ntolgy', Vrije Univcrsiteit Hospital, Amsterdam, The 
Netherlands and Depnrnnent ofDcm1ato tog/, University ofGraz, Graz, Austria 
Homeobox (HOX) genes nrc involved in the lineage specific differentiation of bone murrow stem cells. 
Recently, we reported a largely similar expression pattern of HOXC4 and HOXC6 in nom1al and 
neoplastic ce lls of the lymphoid lineage. In contrast, HOXC5 was specifically expressed in a subset of B-
non Hodgkins's lymphoma (B·NHL), but not in nonnallymphocytcs or lymphoid leukemias. This might 
success a role for HOXC5 in the pathogenesis of these lymphomas. In the present study the expression ~f 
HOXC4, HOXC5 and HOXC6 in primary cutaneous lymphomas was investigated. Using RISH and 
semiquantitative RT-PCR, we found strong expression of HOXC4 and HOXC6 in all , except one. 
primary cutaneous lymphomas a11d all reactive cutaneous lymphoid infiltrates. lnterestingly, n strong 
expression of HOXC5 in primary anaplastic CD30+ large T cell lymphomas wns found. RlSH was 
consistently negative for HOXCS in all other types of primary cutaneous B and T cell lymphomas. 
However, by semiquantitative RT-PCR these lymphomas showed a weak expression of HOXC5 mRNA. 
11tcrcfore, we concluded that these lymphomas express low constitutive lc\•cls of HOXC5 mRNA. 
Furthcnnore, HOXC5 expression was consistently absent in reactive Cutaneous lymphoid infiltrates, 
hyperplastic tonsils and lymph nodes, and peripheral blood lymphocytes either uustimulntcd or 
stimulated by u cocktail ofCD3 and CD28 antibodies. 
Since a strong expression of HOXC5 in primary cutaneous lymphomas was only observed in anaplastic 
large T cell lymphomas and reactive control tissues lacked HOXC5 expression, these datn strongly 
supports a role for HOXC5 in the genesis of anaplastic large T cell lymphomas. 
488 ABSTRACTS 
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SUBUNIT COMPOSITION OF JUN AND MYC DNA-BlNDlNG COMPLEXES IN 
CTCLCELLS 
J.Z. Ojn R. Dummer G. Burg lJ DObbcling 
Department ofDcmmtology, University Hospita l Zurich, Zurich, Switzerland 
Cutaneous T cell lymphomas (CfCLs) arc rcslrictcd to the skin during most the of course of 
the disease and a systemic spread of mal ignant cells to other organs occurs only in the very last 
stages. This is also true to the leukaemic variant the SC:zary Syndrome (SS) in which malignant 
cells also occur in the blood. "Classic" oncogenes like c-jun and c-myc arc only expressed at 
late stages. Members of the jun gene family bind either as homodimcrs or hetcrodimcrs with 
members of the lOs gene family to DNA. Members of the myc family can only bind to DNA 
when they fonn hetcrodimcrs with members of the max gene family. Since the different homo~ 
and hctcrodimerie jun nnd myc complexes can have gene transcription activating or 
suppressing activities we studied the composition of the jun and myc DNA~binding complexes 
in three CTCL ce ll lines and malignant cells of 7 SCzary patients using the electrophoretic 
mobility shift assay (EMSA). Radioactively labelled oligonucleotides containing the binding 
sites of jun and myc complexes were incubated with nuc lear extracts from the CTCL ce ll s 
mentioned above. To determine the composition of the DNA-binding complexes, specific 
antibodies to the different members of the tested gene families were included in the binding 
reactions. Complexes consisting of JunO homodimcrs were found in three ce ll lines and two 
patients. Heterodimers of c~Jun and c~Fos were only observed aficr protein kineasc C (PKC) 
stimulation with the phorbol ester TPA. Tbe three cell lines and one patient contained also c-
Myc/Mnx hetcrodimcrs. Since c-Myc/Max heterodimcrs arc strong gene transcription 
activators and may be necessary for cell cyc le progression, they may play a role in the 
progression of C J'CL. The role of JunO is less clear as JunO has been implied in 
carcinogenesis as well as in tumor suppression. ·n1e experiments with TPA show that the 
regulation of the c-jun nod c- fos genes by PKC is not disturbed in these cells. 
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ISOLATION OF AUTOLOGOUS TUMOR-SI'ECIFIC CLASS 1-RESTIUCTED CYfOTOXJC 
AND I'ROLIFERA TIV~: CD4+CD8+ AND C04+ T CELL CLONES INFILTRATING A CLASS 
II-NEGATIVE T-CELL LYMPHOMA. 
M Bagot H Echchjkjr D Cha01c F Mnmi-Chouaih I poumscl\ A. Bensi!SSan 
INSERM U448, Hopital Henri Mondor, CrCteil, CJF94- l l , Villejuif, France. 
We hnvc isolated severa l proliferative T cell clones from lymphocytes infiltrating a humnn cutaneous T 
ce ll lymphoma, that did not express MHC class 11 molecules. We describe two CD4+CD8dim+ and 
CD4+MHC class !-restricted T cell clones, TCS and TC7, which exhibi ted proliferative and cytotoxic 
activity towards the autologous tumor cells. Interestingly, we found thnt these T ce ll clones were 
similarly able to specifically lyse autologous long-lcmltumor cell lines previously established with rlL-2 
and riL-7 both from the skin and from the blood of the patient Analysis of the T-cell receptor gene 
expression revea led that TCS and TC7 expressed a unique TCR-V8 transcript corresponding respectively 
toVD5-J82.3 and VU17-Ja2.7 gene segments, whereas the tumor cells expressed VB7-JG2.3, VU 13-JD2.5 
and VI322-Jfi2.5 gene set:mcnts. Flow cytometric ana lysis using monoc lonal antibodies against TCR-VIl 
gene products indicated that only VOIJ was expressed on the tumor cell membrane. Next, we could 
sequence the V135-CO and the Vlli7-Cil PCR products, thus con !inning the clonality of the peaks. Using 
clonospec ific probes, we dctemtincd whether these reactive T lymphocytes were present /11 vivo. and 
whelher they could be further expanded ex vi\'0 in short time cocu lturcs with rlL--2 and rlL-7 , The resullo; 
demonstrated that the specific proliferative and cytotoxic CD4+CD8dim+ and CD4+ T cell clones 
developed in vitro were present in the lesional skin site and amplified when the infiltrating lymphocytes 
were cultured with the cytokincs. In contrast, TCS was not detected in the patient pcriphcrnl blood 
ittvadcd by tumora l ce lls. ll1cse results demonstrate for the first time the presence in the skin of reac tive 
T lymphocytes with helper or double positive phenotype infiltrating a cutaneous T cell lymphoma. These 
findings raise the question as to whether these anti-tumoral effector T ce lls participate in tumor 
regression or in contrast omplify the tumor growth. 
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IMMUNOI{JSTOCIIEMI CAL ST UDY OF 100 PARAI'SORIASIS: CORRELATION 
BETWEEN HJSTOLOGICAL ASI'ECI" AND MY7 EXPRESSION. 
B. Dr¢no P . Andres 0 . Jumbou B. Bureau P. Litoux 
Department of Demlatolot,ry, HOtci-Dieu, Nantes. France. 
Parapsorias is en plaque (PP) is considered as an "in si tu" cutaneous T~cc ll lymphoma (CTCL) 
in several s tudies. But at the moment, no biological factor has been isolated as diagnostic 
criteria to correlate the hi stological aspect. In a previous work, we shew that My? antigen 
(COIJ) which is expressed by basal kcra tinocytes in normal and inflammatory owed skin 
disappeared in cutaneous lesions of c rcL. 
·n1e aim of this work was to study the expression of My7 antigen in skin les ions of PP and to 
determine if a correlation may be estab lished wi1h the hi stological aspect. 
59 PP en grandes plaques and 41 PP dig itifonn were studied. The histologic aspect was 
c lassified in: non spec ific innammatory lesions, eczematous lesions, PP, or LCTE. 
The immunohistochemical study was performed on frozen sec tions us ing monoclonal antibody 
My7 (CDI3, Coultron ic). A percentage ofMy7 positive basa l cells was determined (mean for 3 
fields X 3 slides). 
'Inc histological examination showed: 32 parapsoriasis, 13 eczematous lesions, 25 non specific 
innammatory lesions, 30 LCTE. ln a simi lar manner, the d isappearance of My7 expression by 
basa l kcratinocytcs was significantly (p<O.OS) associated with the histological aspect of LCTE. 
So, this study confirms that an histological aspect of CfCL may be observed in PP both in PP 
en grande plaque (40.7%) and in PP digiti form (14.6%) arguing for the hypothesis on an "in 
situ" CTCL. Moreover, My7 appears as a diagnostic cri teria in addition to histology. At the 
moment we arc studying if disappearance of My7 antigen in PP lesions is associated with more 
frequent progression through patch and plaque lesions of CTCL. 
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CELL CYCLE REGULATlNG PROTElNS lN PRIMARY CUTANEOUS T CELL 
LYMPHOMAS 
~1~1 M. Ghislam~onil E. Genti lj1 L. Venegoni1~~ E. Berti1 
Department of Dermatology1, Hospi tal of Busto Arsizio; Institute of Dermato.logical Scicnccs3 
and IV Department of Dermatology2, Saint Paul Hospital, University of Mi lan , Italy 
Transition from G I to G2 phase of the cell cycle is a key moment for cells in as much its 
overcoming entails the admittance of cells in cell cycle phases (S, G2 and M) exclusively 
subjected to inner mechanisms of control. Several chromosomal translocations detected in 
haematological ma lignancies, drive the dclcction or production of spec ific nuclear or 
mithocondrial proteins wh ich function is to lower the threshold of G I phase to external 
mechanisms of control. Nowadays, several monoclonal antibodies able to detect the various 
cyclins, cyclin dependent kineases and cyclin dependen t k ineascs inhibitors differentially and 
tidily expressed in the phases of cell cyc le, arc at our disposal. In order to evaluate S and G2 
fraction cell s (the cellular fraction that has overcome G I phase anti-mitotic externa l signals ), a 
cohort of 30 cases of primary aggressive, intermediate and indolent cutaneous T cell 
lymphomas has been studied for the quantitative expression of eyclin-03, cdk-4, rb- 1, pl6, 
p21, p27, p53, cdc2, cyclin-A, cyclin-B by means of immunohistochemical methods, then 
relating to pro liferation index as detected by usc Ki~67/Mib- l monoclona l antibody and to 
prognosis. Our preliminary results suggest that CTCL characterised by aggressive clin ical 
behaviour (loca l or generalised) arc outlined by an high S/G2 phase cellular fraction which 
absolute value is quite similar to proliferation index. Datn obtained, though not conclusive for 
stringent prognostic considerations, point in light the need to cvn luate :md compare among 
them the different phases of the cell cycle to bcucr understand biological behaviour and, 
indirect ly, to screen CTC L cases, which might present oncogenes amplification or deletions in 
G l phase. 
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ACTIVATION OF PEIU I'llERAL BLOOD LYMI'HOCYTES IN MYCOSIS 
FUNGOfnt:S. 
K. Asadull ah M Friedrich W.O. Dtickc S. Ja lm H.D. Volk W. Steny. 
Departs. of Dermatology and Immunology, University Hospital CharitC , Berlin, Gcmmny. 
Indolent, primary cutaneous T ce ll lymphomas (CrCL) arc characterized by hyperprolifcration 
of malignant T~hclpcr cells in the skin with a favorable prognosis in the early stages. Cytotoxic 
T cells (CTLs) arc believed to be of major importance for tumor surveillance, but there is not 
yet sufficient evidence for a sys temic anti-tumor response in mycosis fungoides (MF). On the 
contrary, there arc hints for systemic immunodcprcss ion. We wondered whether s igns for a 
systemic anti-tumor response were demonstrable in peripheral blood of patients with MF and 
CD30+ p leomorphic T cell lymphoma. Using multiparameter flow cytometry we investiga ted 
blood samples from 39 CTCL patients at different stages in compnri son to those from patients 
with psorias is, atopic demmtitis, and healthy volun teers. In CTCL patients an elevated number 
of lymphocytes expressing natural ki ller cell markers were found, as well as a considerab le T 
cell ac tivation, indicated by increased percentages of T ce lls expressing HLA-DR. IL-2 
receptor a-chain, and transferrin receptor. l11c CDS+ T cells demonstrated to be the strongest 
activated T ce ll subset, were of polyc lonal origin as shown by their usage of different T ce ll 
receptor families . The enhanced expression of activation antigens was associated with an 
increased proportion of CDS+ T cells with high expression of the adhesion molecule LFA- 1, 
demonstrating the capac ity for migration of these ce lls. l11ese CD8+ effector ce ll s arc 
suspected to be crLs and may be responsible for the favorable prognosis of indolent. primary 
C f CL. Interesting ly, a stage-dependent decrease in T cell activation antigen expression was 
observed, suggesting the development of a lack in tumor surveillance in advanced MF s tages. 
Further investigations are necessary to verify whether any of the parameters dctcnnincd arc of 
predictive value for prognosis ;md response to therapy in c rcL. 
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PLEIOTROPIC EFFECTS OF CDJO-CDJOL INTERACTION ON PRIMARY 
CUTANEOUS CDJO+ T-CELL LYM PHOMAS. 
M Mori C. Manuc!li N. Pimninclli M. Santucci1 P Capnugi 13. Giannotti 
Ins titutes ofDem1atology and Anatomic Patholgy1; Univers ity of Florence, Italy. 
CD30 antigen is a member of Tumor Necrosis F11ctor superfamily origina lly identified on 
Rced~Stembcrg cells in Hodgkin lymphoma (HL). "llte biologic significance ofCD30 molecu le 
is strictly related to the existence of a natural ligand (CD30L), recently identified in murine 
activated cells and in human peripheral blood cel ls. Recently, it has been demons trated that 
CDJOL+ cells enhance pro liferation of HL-derivcd T -cclls and, on the contrary, they induce 
cytolytic cell death (apoptosis) of CD30+ anaplastic large cells from nodal lymphomas; this 
ple iotropic activity suggests the possibility that the CD30-CD30L interact ion might play a 
determinan t pathophysiolog ic role in both HL and non-HL. We analysed the phenotypica l and 
gcnotypical expression of C D30 and CD30L in 7 cases of CD30+ CTCL non Mycosis 
Fungoides (non MF), spcclrum of cutaneous lymphoproliferativc disorders including the large 
cell variant (>75% CD30+ cells) and lymphomatoid papulosis, in order to investigate the 
CD30-CD30L cocxpression in different phases of skin lesions (growing vs. spontaneously 
regressing). The immunohistological study (APAAP method) demonstrated cocxpression of 
CD30 and CD30L antigens in regressing lesions only, whi le the molecular study (RT-PCR and 
Southern blot) showed CD30 and CD30L mRNA expression in all examined les ion. n1c results 
of our study, notwithstanding the difference in the resul ts obtained by immunohistochemistry 
and molecular ana lysis (possibly relnted to a quantitatively different expression of CD30L), 
suggest the possibility that the CD30/CD30L interaction my have a ro le in the induction of self 
regress ion (apoptosis ?). 
---
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11'-10 mRNA EXI'RESSION IN CUTANEOUS T CELL LY111l'HOMAS 
C.P Tcnscn M.H. Vcnnccr P. Zondcrvnn S. Lam P.M. v:m dcr Stoop R.J. Scheper D.M. 
Boersma R. Willcmzc 
Department of Dcnnatology and Patho logy, Free University Hospital, Amsterdam, The 
Ne therlands 
IP-10, a CxC chcmokinc, is considered to play an important role in attrncting T cells via its 
chemotactic and ce ll adhesion promoting properties. Recently, also tumor growth inhibitory 
nctivitics have been described. Elevated leve ls o f rP- 1 0 protein h:IVC been found in the 
cpidcm1is of cutaneous T ce ll lymphoma (CTCL). ll1c notion that inliltration of the epidermis 
by neoplastic T ce lls (cpidcnnotropism) is a characteristic feature of early stage CfCL, but 
o ncn disappears with progression to tumor stage CTCL, prompted us to study IP- 10 mRNA 
expression in different skin stogcs of CfCL in order to access its poten ti al ro le in 
cpidcrrnolropism and tumor ce ll growth regulation. 
A quantitative RT-PCR method was developed to determi ne absolute fP-1 0 mRNA leve ls in 
skin biopsies o f early plaque (n=6) nnd advnnccd tumor stage (n=6) CTCL. In add ition RNA in 
situ hybridisa tion ( lUSH) was employed to visualise the site o f IP= IO mRNA expression. lP-10 
mRNA express ion leve ls were correlated with clinical and histological parameters. In the early 
stages o f CTCL up to 1800 copies of IP-10 encoding mRNN ng total RNA could be recovered , 
while this amount declined to I 0 or Jess copicslng total RNA within tumor stages. Extremely 
high levels of lP- 10 mRNA were found in lymphomatoid papulosis, n spontaneously regressing 
type of CTCL. RISH studies showed a strong assoc iation between expression of IP-1 0 mRNA 
in the basa l layer kcratinocytcs und the presence of epidem1otropic tumor cell s. Tite decline in 
IP-10 mRNA levels during progress ion from e:.trly to late tu mor stage CfCL suggests that IV-
I 0 plays an important role in the host immune response and may prevent tumor progression, 
either by attracting tumor infiltrating lymphocy tes or via a di rect effect on the neoplastic T 
ce ll s. 
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CYTOTOXIC RELAT ED PROTEINS EXPRESSION IN A GROUI' OF C DS+ 
I'R!M ARY CTC L 
E. Bcrti1 D. Tomasinil M.H. Vennec~ C.J .L.M. Meijcr1 E. Aless i1 R. Willemz~ 
Institute of Dcnnato logic Science\ IRCCS, Uni vers ity of Milan, Italy; Department o f 
Dcnnatology, Hospital of Busto Arsizio1, Italy; Department of DemmtologyJ and Pa tho logy~. 
Free University llospitn l, Amsterdam, 11tc Netherl ands 
CDS+ primary cutaneous T cell lymphoma (CTCL) arc a group of C l"CL characterised by high 
cl inic;ll agrcssivi ty. Agnarsson, analysing a cohort of CDS+ C r CL patients, has identified an 
aggrcssivc~ac utc and a chronic fom1, the fanner with phenotypica l profile typi fied by C02-, 
CD3+, CD7+ and the latter by C0 2+, CDJ+, CD7-. To understand the cytotoxic or suppresser 
origin of CDS+ CTCL, biopic material obtained from 17 patients, collected from the Iiles of the 
Department of Ocnnnto logy of Mi lnn and of the Dutch Cutaneous Lymphoma Working Group, 
has been ana lysed for cytoplasmic expression of spec ific cy totoxic related proteins (CRP) li ke 
piS T Cell Intracytoplasmic Antigen- I (TIA-1 ) and Granzymc B (GR-B), two CRI' molecules 
respective ly expressed by resting and nctivnted cytotoxic T lymphocy tes (CyT). Their 
expression was finally related to c linica l outcome. Data obtained indicate n greater expression 
ofTIA-1 , being this molecu le expressed by CDS+ neoplastic T lymphocytes in 15 out of 17 
cnscs while on ly 4 were simultaneously TIA- 1 and GR-B positive. CRP expressions was not 
related to prognosis, being these molecu les equally d istributed among aggressive cases (who 
showed 50% and 15% o f survi val respectively nftcr 2,5 nnd 5 years of fo llow·up) and chronic 
fonns, who had a 100% of survival in identica l follow-up periods. Fina lly, in partia l 
disagreement with Agnarsson, we have found a rela tionship between prognos is and CD45RA 
isoform expression, more than with CD2 or CD7 expression. In fact , cases ehnrnctcrised by 
CD45 RA + (lind in the nuivc post thymic CD4+ or CDS+ CyT) or by CD45RA and CD45RO 
double negativity showed un aggress ive cl inical behaviour, while C045RO+ case had a more 
pro longed clinic:.11 course. 
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TIA-t I'OSITIVE SUUCUTANEOUS PANNtCUL TIC y5 T- CELL LYMI' HOMAS. 
~ M I Boulland:o. G Kastylevsky-Choque t1....MJ:L..Q.d(i.!.~J.~...l.. 
~J. ;me\ the French Study Group for 0 1taocous I ymphoma 
Depts of Dennatology1, Patholog/ and lmmunolog/, H6pit31 Henri Mondor, CrCteil, France. 
Only few cases of panniculi tie yl) T-ccll lymphomas have been reported. As nomml yS T cells may 
function as cytotoxic T cells. we stud ied cytotoxici ty associated markers TIA-1 in 2 cases ofyS T-cc ll 
cutaneous lymphomas. 
We report two cases, a 50~year-o ld female who presented with a nodular lesion on the right thigh (patient 
I) and a 14-year-o ld male who presented with an erythematous indurated plaque of the left buttock 
(patien t 2). ·n 1c delay between the appearance of the cu taneous les ions and the diagnosis of lymphoma 
was respective ly one yea r and five months. An initial diagnosis of cytophagic histiocytic panniculitis 
wi th hemophagocytic syndrome had been made in both cases. Histology in patient I demonstroted n yO 
T-cc lllymphoma with on cpidcrmotrophic, dennal and hypodcrnlll llymphoid infiltrate (yS+, ap~, CD3+, 
CD4-, CDS~, CDS-, CD7-, CD56+, TLA·t+). Histology in patient 2 dcmonstrntcd n yS T·cclllymphoma 
with a massive hypodcnual infiltratc(yS+, a~-. C03+, CD4-, CDS+, CDS+, CD7-, CD56~, TIA- 1+, 
gmnzymc+). TCR gene rearrangement stud ies by PCR~DGGE revea led a T-ccll clone in the skin in both 
cases . 
Subcutnncous lymphomas arc rare lymphomas of high grade of malignancy. Only 8% of the reported 
cases were yO T-ccl l lymphomas. 111e diagnosis is often difficult in the initial stages. In our 2 cases, 
tumor cells brightly expressed TIA- 1, a cytotoxic granule-associated protein, responsible for inducing 
apoptosis in cy tolytic lymphocytes targe ts. TIA-1 is expressed in NK cells, cytotoxic CDS+ T cells and 
nom1a l yO T cells. TIIis cytotoxic activity has been implicated in the development of necrot ic lesions in 
some yO lymphomas and might be associated with a poor prognosis. 
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ANALYSIS OF V 11 GENE REARRANGEMENTS IN SINGLE B CELLS CONTAINED 
lN DERMAL JNFIL TRATES OF PATIENTS WITll MYCOSIS FUNGO IDES. 
S. Gellrich N. FOrstc S. Golembowski S. Rufz H. Audring S. Jahn W. Sterry 
Department of Dermatology, Medical Faculty (CharitC), Humboldt University Berlin, 
Gcnnany. 
In some patients wi th primary cutaneous T-celllymphomns like mycosis fungoides numerous B 
cell s can be detected conta ined in the lymphocytic dcnnal infiltrate. To rmalyse their 
immunoglobulin heavy chain gene repertoire s ingle B cells were obtained from tissue sections 
of two patients with mycosis fungoidcs using hydraulic micromanipulation fo llowed by specific 
amplification of the respective gene segments applying a single ce ll PCR technique. A total of 
21 V11 DJ 11 genes was sequenced. From each individual 8 cell a single productive VuDJ 11 
rearrangement was obtained. There was no clonal relationship detected between any of these 
rearrangements suggesting polyclonality of the infiltrating B cells. The distribution of V 11 
famil ies was in accordance with the gennline complexity. A remarkably high number of V11 
genes (5/ 13 in pa tient 1; in 3/8 pntient 2) was characterised to be completely or nearly 
gcnnline·idcntica l. Whereas most of the V 11 3 gene fami ly members used in this repertoire were 
somatica lly mutated in an antigen-driven manner, sn V1t4 genes were nearly urunutatcd. 
Summarising the proportion of gennline identical V 11 genes, the usage of individual V 11 gene 
clements, and the pattern of somatic mutations in their V11DJ11 rearrangements found in B cells 
infiltrating skin lesions in cutaneous T-ec111ymphoma patients reflect features of the peripheral 
blood repertoire. 
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CYTOTOXIC PROTEIN EXI'RESSION IN CUTANEOUS 1'-CELL LYMPHOMAS. 
M.L. Boullnnd1 P Gnulnrd1 M.H. Delfnu1 M. Bngor ~ ... 
Departments ofPatho logy1, Immunolgland Dem1atology, I-16pitnl l-1cnri Mondor, CrCteil , 
France. 
Cytotox ic cells arc known to play a major role in the defense against neoplastic processes and 
viral infections. They include NK ce lls, cytotoxic CDS+ T cell s and nonnal yO T cells. We 
postulated thnt the presence of cytotoxic cells within the infiltrates of cutaneous T-ccll 
lymphomas could influence the 'prognosis of these tumors. Recently, the development of 
monoclona l antibodies nga inst human cytotox ic proteins have mndc the immunohistochemical 
identifi cation of ce ll s expressing these proteins possible. Our objecti ve was to sec whether the 
expression of these prote ins displays d ifferent patterns in cutanCO LJ S T-ccll lymphomas. Using 
monoclonal antibodies on paraffin-embedded sections, we studied 54 cases of cutaneous T-cell 
lymphomas for the expression of TIA-1 and granzymc B proteins, granule-assoc iated proteins 
o f cytotox ic lymphocytes involved in the mechanism ol' apoptosis. We showed that 67% of 
CDJO+ T-cc ll lymphomas (6/9 cases) expressed nt least T IA-1 and that 88% of lymphomatoid 
papulos is (15/17 cases) displayed TlA-1 and/or granzymc expression in virtua lly all large 
atypical ce ll s. The two COS+ cases ( I mycos is fungoides and I pleomorphic lymphoma) 
expressed T IA- 1 and granzymc B in the 111mor cells, whereas on ly scattered reac tive 
lymphocytes expressed cytotox ic proteins in CD4+ mycosis fungoidcs (13 cases). Sezmy's 
syndrome (2 cases) and CD30~ CD4+ pleomorphic lymphomas. In addition, our results further 
support an overlapping between two disti nct clinical enti ties such as lymphomatoid papulosis 
nnd CD30+ lymphomas. 
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IND UCTION OF INTERt'ERON-IND UCUILE PROTEIN-10 tlY TUMOR NECROSIS 
FACTOR-n JNTERFERON-y. OUT NOT DY 1-ITLV~I IS LIKELY TO EXI~LAIN Tl·fE 
EPIDERMOTROI' tSM OF CUTANEOUS T c•;LL LYMPHOMA 
A H Sarrjs D pa!inni C Jackow \V Pugh B G:msbachcr F Caba nmns M Duvjc 
l l1e University of Texas l\•t.D. Anderson Cancer Center, Houston, Texas; TI1c Uni\'ersity of Texas 
Medica l School, Houston, Texas; Memorial Sloan-Kctering Cancer Cen ter, New York. New York 
Interferon-Inducible Protcin- 10 (I P-10) is a cytokinc chemotactic for CD4·positive lymphocytes thnt is 
expressed by basa l kcratinocytes of normal epidcmtis. TN F-a is synergistic with IFN~y for thc induction 
of 11,- 10 by kerntinocytes. ·n1c tax gene of human T-lymphotropic vinas-1 (HTLV-1) immorta lises CD4-
posith•e lymphocytes. induces IFN-y, and has been detected in variable numbers of patients with class ic 
cutaneous T cell lymphoma (CTCL) who arc sc.ronegativc for HTLV~l. We therefore decided to 
determine the presence of IJl- 1 0, IFN-y, TNF-a, and tnx in lesions of adults with untreated classic CfCL 
who IVCre seronegative for HTLV-L IP~lO, TNF-a and IFN-y were detected nnd localised with 
immunohistochemistry of frozen sections. In addi tion, Iesiona l mRNAs for actin, TNF- a, TFN-y and tax 
were detected by rcversc-transcriptase polymerase chain reaction (RT~PCR) amplification. I P~ I 0 was 
ovcrcxpresscd in lcsional kcratinocytcs of 50/51 patients where it wns detected throughou t the epidcmtis. 
Oy RT-PCR, mRNA for IFN-y was detected in lesions of 8/19, and for TNF~a in lesions of 13/19 
patients. Oy immunocy tochemistry, TNF-a was expressed by lesionnl kcrntinocytcs in 10/ IJ tested 
patients, whereas IFN.y was foca lly expressed by lcs ionnl lymphocytes in 9/13 tested patients. Tax 
mRNA wns detected in lesions of 0/19 patients, but was easily detectab le in cutaneous lesions of 
peripheral blood of control pat ients with T cell malignancies who were seropositive fo r HTLV-1. We 
conclude tha tiFN~y secretion by C I'CL may induce I P~IO secretion by epidcnnal kcratinocytes and thus 
fom1 a cytokinc loop responsible for the epiderntotropism of CTCL. lNF~n may contribute to 
cp idem1otropism by syncrgizing with IFN~y in the induction of lP- 10- Howc\'er tltc tax gene of HTLV~l 
docs not appear to be involved in classic CTCL. These cytokinc loops may be exploited in the design of 
novel therapies for CTCL. 
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CYTOTOXIC T LYMPHOCYTE ACTIVITY SPECIFIC FOR MALIGNANT T CELLS 
IN A PATIENT WITH SEZARY SYNDROME: IMJ'LICATIONS FOR THE 
MECHANISM OF INTERFERON-y TIIERAPY 
Y. Tokura N Seo M. Jakigawa 
Department of Ocnnntology, Hamamatsu Universi ty School of Medicine, Hamamatsu, Japan 
ll has been suggested that CDS+ cytotoxic T lymphocytes (CfL) serve as a tumoricidcr against 
malignant cutaneous T cell lymphoma (CTCL) cells. When malignant T celts arc of a Th2·typc, 
the activities of lll\ cells, CTL, and natural killer cells arc expected to be depressed. We 
investigated the tumor-specific cytotoxicity of CDS+ T cells residing in periphera l blood of a 
patient with advanced SCzary syndrome of1b2 type, focusing on the effec t of intcrlcukin 2 (IL-
2), interfcron-y (lf'N-y), and IL-1 2 on their cytotoxic activity, and the re lationship between 
their lyti c capacity nnd the patient's c linical course. At four different time points during a tw.o-
month clinica l period, C04+CD7- SCzary tumor cel ls and CD8+ T cell s were separated from 
patient's c irculating cells by negative and positive selections wilh immuno-magnctic beads. 
CD8+ T cells were cu ltured with chemically aucnuatcd SCzary ce lls in the presence or absence 
of cytokines. When cultured with IL-2 , COS+ cells ex.hibited speci fic lytic activity. 1FN-y or 
LL-12 exerted a synergizcd cyto lytic effect with IL-2 on the tumor cells. Cloned CDS+ T cell s 
from the CfL population were induced with IL-2 nod k111ed autologous tumor cells in MHC 
ci<Jss 1- anti T ce ll receptor-limited fashions. During the pt~ticnt's clinicol course, the cytotox.ic 
activity an~ number of CDS+ T cells were inversely correlated with the disease activity ns 
assessed by the serum level of LDH. "Ibis suggests that CfL down-regulate the growth of 
mali~nnnt T cells in this long-standing disease. Our study also implies the mechanism -by which 
rFN·y Cxcrt the therapeutic e ffectiveness in the trea tment of C f CL. 
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GRANULOMATOUS SLACK SKIN 
C W van l! asclcn1~1 S J S van der Jluttcl C I M yan HccsL J J M 'iiln Doogcoi~ 
~.l. Department of Dcmlatology and Patl!ology\ University Hospital of Utrecht ; Department of 
DcnnatoJogy, University Hospital of Lcidcn,, Department of Immunology\ ErJsmus University 
Rotterdam; ·n,c Netherlands 
Granu lomatous slack skin (GSS) is a rare cutaneous disorder characterised c linically by the evolution of 
circumscribed erythema tous lax skin masses especially in the body folds, and histologica ll y by 
grnnulom3tous T cell infi ltrate and loss of clastic fibres. GSS is often associated with precceding or 
following lymphoprolifcrativc ma ligna11cies especially mycosis fungoides (MF) and Hodgkin 's disease 
(liD). No effect ive treatment is known yel. 
Whether this en tity is a benign disorder, a peculiar host reaction to a malignant lymphoma, a precursor of 
maligna nt lymphoma, or an indolent cutaneous T ce ll lymphoma (CI'C L) in ilSelf, is stilt a maltcr of 
debate. 
111c results of three patients with GSS from the Netherlands arc compared with the cases reported in the 
world literature. A female patient had GSS since 8 years wi thout deve loping a secondary maligr~:mc·y. In 
a second female patient with a histologi ca lly confinncd diagno!!is of MF, GSS developed 18 years later 
in the ax illary and lingua l folds that were previously affected by plaque stage MF lesions. A third male 
patients with a 6·year-history of erythcrnatosquamous skin disease diagnosed as c rCL developed GSS. 
Granuloma fofJ!lation was also found in a facial basal cell carcinoma, in a lymph node in the neck, and 
the splee n. 
Clona l rearrangements of tl1e T ce ll receptor I] genes were found in both studied female patients (land 
II). . 
·n,c dcvc lopm.en! of QSS within plaque MF lesions has not been rcportc4 before. As compared to follow 
up of earlier reported patients, the third ca::;c described by us developed very ex tensive skin lesions and 
showed a strong propensity to develop grnnulomas. 
We hypothes ize that GSS is a very rare and rather indolent variant of CI'CL. Long term follow up is 
needed because in about 50% a second malignantlymphoproliferativc disease occurs. 
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THE IMMUNOl'ATHOGENESIS OF CUTANEOUS T-CELL LYMJ'HOMA: TilE 
CAS!l FOJllllOLOGICAL RESI'ONSE MODIFICATION 
A 1·1. Rook FE Fox. 
Department ofDcnnatology, University of Pennsylvania, Phillldc lphia, PA 
Cutaneous T-cell lymphoma (CfCL) is a clonally-dcrived, skin-invasive malignancy of CD4+ 
T -lymphocytes with the phenotype of mature helper T -cclls. J>r~vious work from our laboratory 
has demonstrated that the Se1.ary fonn, or typically leukemic form of crCL, is characterized 
by prominent immunologic defects including depressed cell-mediated immunity. We have also 
demonstrated increased production of T-hclper type 2 (Th2) cytokincs ( IL-4 , IL-5) by the 
ma li gnant T-cclls and deficient 1111 cytokincs (IL-2 and interferon gamma [IFN g)) by their 
periphera l blood ce lls (PBMC). We have a lso noted a marked defect in IL-12 production in 
C fCL which may also play a role in depressed ce ll ·mcdiated immunity. Overall, our data 
sugges t that the immune aberrations can be onributed to the cytokinc nbnonna lites triggered by 
the malignont T-ecH population. Since CTCL is a disease that is responsive to biological 
response modif1cation, we have focused on strategies for reversing the cytok ine and immune 
defects by in vitro testing of available, and novel biologic response modifiers including IFNa, 
IL·l2: IL-15 and rc tinoids. Oll r results have indicated that IFNa potently suppresses the 
abni:mna l JL-4 and IL-5 production and that fL.J2 can correct the deficient I.FN g production 
and that rctinoids can induce IL·I2 production. We have also commenced studies of the in vitro 
growth characteristics of the malignant CD4+ cells and have dctem1incd that IL- 12 and t:FNa 
significantly suppress growth of the malignant cells. These studies have led to a phase I trial of 
IL- 12 to treat CTCL. This work has defined mechanisms of action of biologic response 
modifiers and has 
targeted potential future combinations of therapeutic biologic agents for CTCL. 
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CYTOTOXIC RELATED I'ROTEINS EXPRESSION IN A GROUP OF PRJMARY 
CTCL 
D. Tomasini1 M . Gbis lanzoni E. Gcn til i L. Crosti I. Dcclcv;J R. Caputo E Berti 
Department of Dermatology', Hospital Busto Arsizio; Institute o f Dermatologica l Sciences, 
IRCCS, Un iversi ty of Milan , Italy 
Cytotoxic T Lymphocytes (CyT) (either CD4+ or CDS+) ore defined by the presence of 
cytotoxic functionnt proteins (CFP) like the p lS T cell intracytoplasmic antigen-! (TlA-l ), 
perforin and gmnzyme. In a previous investigation, CFP expression hns been demonstrated in 
CDS+ primary cutaneous T cell lymphomas (CTCL). Guessing that CyT might a lso be 
expressed from a subset of CD4+ CTCL, 94 P.aticnts respectively suffering from mycosis 
fungoidcs at different stage (MF, 28 cases), erythrodermic CI'CL and SC7.ary Syndrome (SS, 8 
cases), Pleomorphic T cell Lymphoma ·(PTCL, 7 cases), y,O+ lYmphoma (Ly/0, 2cascs), 
lymphomatoid papulosis (LyP, 16 cases) CD30+ large cell lymphoma (LCL, 28 cases), 
subcutaneous c rcL (SBL. 5 ca!iCS) and 4 cases of Mucha-Habcnnann disease (PLEVA) were 
invesiiga ted for cytoplasmic expression ofTJA- 1 and gnmzyme B (GR~B). Results are given in 
fraction of positive cases and Overall tested cases. A) Tia- l : M.F8128,SS 0/S, PTCL 2fl , SBL 
4/5, Ly/5 212, Lyl' 16/16, LCL 15/28, PLEVA 4/4. GR-B: Mf 1/28, SS 0128, PTCL 0/7, SBT 
1/5, Ly/5 2/2, LyP 5/16, LCL 6/28, PLEVA 214. While CFP arc observed only in variants of 
MF like Pagetoid Reticu losis or r<Jrc cases of tumor s inge MF, they show a grea ter distribution 
in Ly/5, LyP. LCL and in SBT. A positive relationship has been observed among CFP 
expression and early histo logical alterations like the presence of necrotic kcmtinocytcs. 
Clinically, TfA- 1+ cases were also characterised by many ulccro·necrotic lesions. Further, 31 
among the 5 I CFP+ cases were typified by the phenotypical eXpression o f sevcru\ receptors of 
the TN!' family . Finally c linical outcome of TJA~I + Cnses was s imilar to TIA-1- cases. In 
conclusion, also if CFP expression is not directly related to prognosis, CFP pos itivity might 
ex plain some elinicu l features o f specific C r CL subsets. · 
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I'.RJMARY CUTANEOUS CD30+ LYMJ'HOI'llOLIFERATIVE DISORO.: RS llA VE A 
CD4+ CYTOTOXIC T CELL PUENOTYI'E 
M.H. Vermeer J.A. Kummer C.J .L.M. Meijer R. Willemzc 
Departments of Demmtology and Pathology, Free University Hosp ital , Ams terdam, The 
Netherlands 
l)rimary cutuncous CD30-pos itive (anaplastic) large T ce ll lymphomas and lymphomatoid 
papulos is (LyP) arc closely related types of cutaneous T cell lymphoma with a favourable 
prognos is. l1lc neoplastic T ce lls in these cond itions bave the phenotype of activated CD3+, 
CD4+, CDS-, CD30+ sk in homing T cell s, but their nonnal counterpart has not yet been 
defined. 
To further characterise the cclhtlar origin of the neoplastic T cells, skin biops ies from ~4 
patients with a primary cutaneous CD30-pos itivc (anaplastic) huge T cc lllymphomil, 9 patients 
with Ly P, nnd six primary cutnneous CDJO~ncgutive pleomorphic large T cell lymphomas were 
stained with monoclonal anti_bodies against cytotoxic cell-associated molecules granzymc B 
andTIA-1. 
In 9/9 LyP and 10114 C030-posi tivc primary cutaneous large T cell lymphomas expression of 
granzyrne Band TIA~ 1 by va riable numbers of neoplastic cells was found. In most cases equa l 
numbers of granzyme Band TIA-1 positive tumor ce ll s were observed. In Gn CD30·ncgative 
primary cutaneous large T cell lymphomas, the neoplastic cell s did not express these proteins, 
whi le in one case a sporadic positive tumor cell was found. These results demonslralc that1 in 
contrast to primary cutaneous CDJO-negativc pleomorphic large T ce ll lymphomas, the 
neoplastic cel ls in most primary cutaneous CD30-positivc (anaplastic) large T cell lymphomas 
and LyP have ~~ specific C04+, CD8- granzyme B+, TIA-1 + phenotype, and can therefore 
considered ns the neoplastic equivalents of a peculiar subset ofCD4+ cytotoxic T cells. 
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F.LUDARAIJINE I'UOSI'HATE IN ADVANCED MYCOSIS I'UNGOIDES/SEZARY 
SYNDJIOME: A I'JlASE ll TRIAL. 
M.G. Bemengo M.T ·ri cJTO P. Ouag\ino A. Verrone 
Department o f Mc~ical and Surg ical Specia li ties, Dcmmtologic Section, 1•1 Dcmmtologic 
Clinic, University of Turin , Italy. 
Fludarabinc is an adenine nuc leoside ana logue with promising activity in low-grade non-
Hodgkin lymphomas. Preliminary reports have suggested its potential clinical activity in the 
treatment of advanced Cutaneous-T-Ccii -Lymphomas (CTCL). ·i11e a im of th is study was to 
assess the efficacy and toxicity of fludarubinc in patients with advanced or refractory Mycosis 
"rungoidcs (MF) or SC7.ary Syndrome (SS). · 
Nineteen patients (13 MF, 6SS) were treated with fludarabinc at a dosage of 25 mg/m2 
intravenously on days I to 5 every 28 days for up to eight cyc les; seventeen { 12 fy1f/5 SS) arc 
evaluable for response. MF patients were classified according to TNM staging system (5 stage 
Ub, 7 s tage IVa, l stage JVb) . Ten patients (8 MF/2 SS) had rece ived prior chemotherapy. Four 
out of twelve Mr patients achieved a partial remission (PR) (response rate : 33%), with a 
median response duration of 7 months (rn!lgc 3+ - 10 months). Conversely, 3/5 SS patientS 
achieved a c lin ica l response (2 CR, I PR) , for an overa ll response rate of 60%. Another patient 
showed a cutaneous stable disease, with a more !han 50% reduclion in the numbCr of 
circulating Stzary cells. ln a ll patients a remarkable reduction in Pruritus was seen. Median 
response induction time was 3.5 months (range:: 1-4). Remission durations were 5+, II and 24+ 
months. Systemic side effectS and toxicities were unremarkable; cutaneous rashes were 
observed in 8 patients, whereas only I case of grade I neutropenia occurred. ·n1csc results show 
that fludarubine is an effective and well-tolerated first-line chemotherapy in SS; conversely, in 
tumor stn.gc MF patients, nudarabine results do not compare favourable with other therapeutic 
approaches (i.e. VICOPB). 
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I'ROGNOSTIC FACTORS IN SEZARY SYNDRO~~J' 
M.G. Bcmcn(!o P Omu;\jno M Nove ll i N. Cappello- G.C Oovcil r. Lisa A. de Mnt1eis 
M.T. Fierro A. Apr ino 
Department of Medical and Surgical Specinlitics - 1st Section of Dcm1ato logy, University of 
Turin. Ocpar1mcnt o f Generics, Biology rmd Mc9ica l Chemistry', Univcrsily of Turin, Turin, 
Italy 
SCzary syndrome prognostic factors ar.c quite unknown. However, clinical histopathological 
und gcnotypicu l s tudies have suggcs.tcd that SS is a heterogeneous gro up which may comprise 
forms wi th a d ifferent clinical course. The specific goa l of this prospective study was to assess 
by mulliv~rin tc an<~ lysis the predictive value of a series ofcliniclll, hacmutological and 
immunologica l f11c tors and their influence on surv iva l. A cohort of 62 SS patients diagnosed in 
our C linic si nce 1975 was examined; 5 1 were included in the mu ltivariate ana lysis mqdcl. 
Oiognostic criteria were: a) crythrodcm1a and pcriphcrallymphadcnopa thics; b) c irculating SC 
greater than or equal to I 0% of peripheral blood leukocytes and greater than or equal to 
I 000/mm'; c) cutaneous and nodal biopsy proven CTCL. Median surviva l time was 48.2 (range 
I month·l5 .5 years); 5-ycar surv ival rate 43. 7%. The variables selected as adverse independent 
prognostic factors were: high 1lumbcr of circulating SC. presence o f la rge SC. PAS pos itive SC. 
lack of CD? expression and previous history of documented MF. On basis of these data, a risk 
index has been calcula ted uSing Cox model and two \ow/high ris~ (risk index< or > I) groups 
have been singled out. Survi val differences between the two groups nrc slriking (5 years 
survival: 60.8% vs. 8.3%). Even if our model needs to be conlimtcd by larger groups of 
patients, we fee l that may be of c lin ical relevance in improving SS knowledge and 
manngcmcnl. 
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LONGTEitM EFFICACY 0 1' ORAL I' HOTOCilEMOTIU:RAI'Y IN MYCOSIS FUNGOIDES 
H Majer B S!ndlb;;ucr F Trautjm:cr R. K110blcr A Tnnew 1·1. HOnj~.:smn nn 
Department of Special nnd Enviromcntal Demlato~ogy, Univcrsily of Vienna Medica l School. Vienna. 
1\us1ria 
Since the introduction of om! photochcmothcr.tpy (PUVA) as treatment modality for mycosis fungo ides 
(MF) the question Is st ill unanswered, whciher PUVA can induce pennancnl remission. 
In order to evaluate longterm efficacy we rc\•icwed the fa te of 22 MF patients (5 lA, II ID, 3 II A, I l iD , 
1 111 , I IVA) in whom PUVA h;1d been ini tiated before 1987. Six mnlc and 4 fcnm lc patients (3 lA, % 
IB," II A) of the 12 MF pol icnts who did not appear nl fo llow-up had di~:d . One palien t wi th initial slagc 
IB disease had died of septicaemia which may be n:/ated to his progressive tu mor. In all other deaths no 
post-mortem reports were ava il able. According to the records 5 patients (2 Ill, 2 II A, I Ill) had 
progress ive disease (I li B. I Ill , 2 IVA), 3 patients ( I 'lu, I 113, I IVA) had rema ined in the same stage 
and 4 patients ( I lA, 3 Ill) showed clear improvement at the last recorded cxn minali(ln which was 10 
(0.5·26) yea rs 111ea n a ncr the diagnosis of MF and 2.3 (0~3) motllhs mean al\cr the lust PUVA session. 
11tc mea n period from .thc initialion of PVVA to fo lloW· Up was 167 ( 125·258) mOn! h. All but one 
fol low·up patient with stage Ill disease had a history ()(two or more PUVA courses . 4 fo ll ow.up patients 
(I tA, 2 10, I liD) had reCeived adjuvant loca l X·mys und one patient wtth stage IB disease had been 
treated ndditionnlly wi th eXtracorpora l photochcmothcrapy. 62 ( 2· 195) month afler the last PUVA 
trcal!nen t complete remiss ion was found in fi ve patients {I lA. 3 lB. I IIA). ·ntc longest discase·ftec 
periods afic r the last PUVA session were found in 2 stage Ill patients, 123 and 195 monlhs respeclivcly. 
In 2 stage lA patients the invo lved are:t was less 1he I% of body surface nt fo\low·up nnd one in patient 
with s1agc liB disease the skin was cleared except one single tuntor by four consecutive PUVA courses. 
All fo \low·up patients were alive and in good condition 12 · to 34 (menn 22.8) years after the first 
symptoms of their malignant disease emerged. 
Summing up, our data ind icate that oral photochemotherapy alone or in combination with other 
treatment moda lilics may induce longtcnn remiss ion in MF patients with early disease. Furthemmre~ it 
scCm~ to be possible to maintain the same stage of disease fo r a long period even in some cases of 
advanced MF. 
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CHRONIC D~RMATITIS ENVOLVING INTO SEZAilY SYND!!OME IN 2 YOUNG ADULTS 
C W. va n 1-laselcnl....l.....Iillul A l-1 Prccsman1 S.C.J van dcr Puucl C A F M Bmynzccl-Koomcnl. 
W A van Vlotc/ · 
Departments of Dcnnatology/AIIcrgology 1 and Patholog/, University Hospita l Utrecht, 11te 
Netherlands 
St:zary symlrmm: (SS) is a variant of cutaneous T cell lymphomtt (CTCL) characterized by 
erythroderma, lymphadenopat hy and the presence of ci rculating atypical lymphocytes (SC'l.nry cells ). SS 
has a pcUk incidence in ntiddJc aged persons. According to epidemiolog ic s1udics and case ro.:ports, 
pa tients with CTCL can have innanmmtofy ~enuat i ti s , including atopic dermatitis before they develop 
their cutaneous lymphoma. 
In the few Patients who developed SS at a you ns age the crythrodcmta was not evolving from a pre-
existing dermatitis neither associated with an a!opic di:t thcsis. Two young p:llinas arc presented who 
developed SS at an unusua l young at;c after a period of chronic demtat itis. A 23-ycar-old male patiem 
with a history of severe atopic demmli tis since childhood, developed SS aflcr 9 years or crythrodcml:t. A 
29·ycar-old fcrn:tle pal iCill developed S~ ':~fl,er II ,recalcitrant eczema wi th Ctylhrodcrma of 4 years 
duration. Titcsc cases contrib ute to the st ill ongoing discussion whcUtcr there ex ists a relationship 
between inn:numatory dcnnatitis and subsi.:qucnt $S or not. In the presented patients wi th chronic 
dcrmntitis t1 S}'Stet;ti c Jymphomn developed 011 :i young age, llltlking a co incidence! there fore unlikely . 
We hypothesize that, in indiv idua ls wi th genetic ' su~ceptible lymphocytes nn atopic/chronic dermatitis 
may aspccifical\y st imulate these cells and co ntribu te t.o thcif escape frorn immunologic control. Th is 
mechanism offers an explanation for an association between a pre-ex isting dcnnati tis and the 
dcvclopmct!l of SS on m1 wmstwJ you11g :1gc in tJJeS~ two paticu ts. 
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TREATMENT OF CUTANEOUS T-CELL LYMPHOMA WITH LOW DOSES OF 
INTERFERON ALPI:IA-2B. . 
M.H Chen 13 S Ojn. !nstihlle or Dcmlatojogy, Hua Shan Hospital, Shant;hni Medical University, 
Shanghai 2000~0, PR China. 
11tis study was designed 10 eva luate the opl!mnl dose and route of inlcrferon alpha-2b (INF·a-2b) given 
to the Chinese Paticll\s with cutaneous T·cc\l lymphoma (CfCL). 16 patients with CfCL treated with 
INF-Ct-2b were divided into groups accord ing to the TNM classification: l 0 (8 patients), II A {2), II 13 
(5) and IV 13 (I). Ourint; induction INF-a·2b were given intro museularly every day or two times a week, 
bcginnint; with a dose or 1·3 x 10"' IU. Depending on the patients lolcna nce level, the dosage could be 
increased weekly 10 n maximum toh:rated dose of IS x 10' IU (mcun, 6 x I 06 IU/wcek) o.dmin istcred two 
or three times ::~ week. Patients with cl inical response were maintained at initial dosage, Thereafter the 
dosngc were gradually decreased afte'r disappearance of skin lesions. 3 patients were treated by 
combining int ramuscular and intralcsion:ll injection or INF. 6 palicnts (I 13 , 2: II A, 2 and II B, 2) 
achieved con1plcte response {CR). 7 patients (I U, 5; II D. I and tV D, I) showed pa rtial response (PR). 
'!111! overa ll response rate in th is group was 81,25%. 1l1e prominent initia l clinical response in 3 patien1s 
were mani fes ted early at one week nfter the intramuscular injection ofiNF and then the skin lesions were 
resistant to the 1herapy bu t disappeared rapidly by combining intralesion:~ l injec tion of INF. llte 
coudilions or those pa1icn1s obtaining CR wilhin 3 10 6 weeks were slab'ilizcd ror 1-36 weeks. Minor side 
effects have been observed in .:t patients wi th ''Ou-like" symptoms and I pa1icnt with low fever. This 
study demonstrated that the overall response rote in treating Chinese Patients with CTCL was 8 1,25% 
and higher {85,7o/or-87,5%) in the subgroups at early Mages of disease progress. The authors believe that 
Chinese Patients with CI 'CL may have a diffcrcm tolerance dosage for INF trcatjllcnt. Starting with low 
doses of INF treatment may help to dctcnnine the optimlll dosage for different patient and achieve a 
more cost-e!Tec tive mtio in th e treatment. lntralcsionnl injection of INF could be recommended for 
achieving longci periods oft1Jcrapcutica!l}' active serum concentmlion. 
46 
I'RELIM INARY RESULTS QF TilE TREAnn:NT pF CUTANEUS LYMJ'HOMAS 
WITH GEMCITAiliNE. 
G. Modugno G. llalivn G. Lombardo A. Mononuli R. Simoni 
tor - lnstituto Dcimopatico ddl' hnmncolata - I.R.C.C.S., Rome. Italy 
Gcmcitnbinc. a novel nuc leoside analogue. has been shown to be active as single :1.gcnt in m:1.ny 
so lid tumors , p:irticularly in advanced NSCL, bre:1.st ~:md pancreatic cancer. We tested efficacy 
and toxicily or gcmcitnbinc in 7 pre-treated patients (pts) affected \~y cutaneous lymphomns. 
!•a tients' ehamctcristics: 6 males :1.nd I female; median age 70 years (rnnge 4 1·93). Histology: 
Tccl!: 6IJIS, 0 cell : I pl. Prc·tre.atmcnt consisrs ofinlcrfcron (IFN) l p!, l FN and chemotherapy 
4 pts, plesiothcrapy 6 pts , PUVA 6 pts. Gcmcitabine was admini stered: 4 (lpt), 2 (lpt) 1 I (Spt). 
In 2 pts the:: third dose wns omitted due to WHO grade 3 thrombocytopcnin and leukopenia. No 
clinica lly relevant toxicity Wf\S rcpot1cd. ln the 5 patient~ eva luable fo r response we observed: 2 
comple te response and 3 partia l responses, a ll appearing a fter the first dose of geploitnb ir)c. The 
study is going on. 
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LEUKEM IA CUTIS: A CLIN ICO I'ATilOLOGICAL ANALYSIS OF 29 PATIENTS 
W.A Vjlll Vlt1tcn J 0 S E Dnnkerlui J. T oonsi-ra S.C. I v;m de Puttc A W Dekker 
Departments of Dermatology, Pathology and Hacmatology. UnivCrsily Hospital Utrecht, 11tc 
Netherlands 
Lcukacmin Cut is (LC) is known 10 occur in palicnts during the course of \cukncmia. In part of 
the patients LC is the presenting symptom, whi.!thcr as first s ign of the disease or as sign ~fa 
rclnJ>SC of a treated leukaemia. 
We ana lysed 16 m~tlc and 13 fema le patients (Frcnch·Amcric!!n·Bri ti sh classification for non· 
lymphocytic leukaemia M2=4; M3= 1; M4=7; M5= 12; ALL= I; CLL= I; CML=3). 
Fourteen patients had C L :ts presenting symptom of which 7 showed no detec table boncmarrow 
involvement. The interval between cutaneous diagnosis and nppear:mcc of systemic leukaemia 
varied from Q.9 months. Fifteen pnticnls developed LC during the co~rsc of discnsc after 1·50 
months si nce the diagnosis of leukaemia. 25/29 were treated with swndart polychemotherapy. 
A ll pnticn!s died a ncr 1·34 mon{hs since the diagnos is of LC. The skin lesions consisted of 
nu1 cu les, papules nne\ nodules. LC may minlic other dermatoses. 
·n1e cutaneous infi ltrate varied from pcriv:tsculur to diffuse. The infiltrate showed a 
monotonous proliferation ofatypicalmcdiumsizcd monocytoid cell s with a moderate nmounl of 
fn intly stained cy top lasm nnd round to ovnl or s lightly indented nuclei. A moderate number of 
mitosis was present. 




ECP VERSUS ECP+IFNa. IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA. A 
RETROSPECTIVE EVALUATION USING A NOVEL CUTANEOUS T-CELL LYMPHOMA 
SEVERITY INDEX (CTCL-SI). 
H J Schrag E Djppel S Gocrdt C E Orfanos Department of Dcnnatology, Benjamin Franklin 
Medical Center, The Free University of Berlin, Berlin, Genn.:my 
Introduction. Iloth cxtrncorporeal photophoresis (ECP) or intcrferon·et 2a (I.FNa. 2a) have been shown to 
be effective in patients with cutaneous T-ce ll lymphoma (Cl'CL) when used as a single treatment 
modality. However, there is still data lacking about the efficacy of combined regimens. Thus, our 
purpose was to compare ECP to ECP+J:FNa. in patients with advanced C f CL and evaluate t11cir response 
rates with a quantitative scoring system. 
Methods. 19 patients with advanced CfCL who had received ECP (n=IO) or ECP+IFNa 2a (n""9) 
between 1992 and 1996 were reevaluated and statistically analyzed with a newly developed quantitative 
scoring system; cu taneous T-cell lymphoma severi ty indelC (CTCL- SI). CTCL-SI includes parameters 
such as skin area involved by patches and plaques, the number of tumor lesions, the occurrence of 
dcrmatotypic or specific lymph node involvement, the percentage of circulating atypical cells, ond the 
number of viscenl org:ms involved. CTCL-SI response rate (CTCL-SI' R.R) was defined as follows: 
(CTCL-SI p•cuu•mon•" CTCL-SI ~""'"o••m••'/ CTCL-SI "'"" .. """"') x 100% 
Results. ~Of the 10 patients, I showed n complete response (CR), I showed n minor response (MR), 
and 8 did not respond to treatment (SD. The mean CTCL-SI showed none statistically sign ificant 
improvement {CTCL-SI R.R= i .4%]). ~Among the 9 patients, 4 showed a CR, 2 showed n PR, 
2 showed SO, and I showed progressive disease. TI1e patients treated with ECP and IFNa 2a showed a 
median CTCL-SI RR of65,7% (p=O.O I) as compared to pretreatment measurcmcnu. 
Conclusions. l11c results of our pilot study indicate that ECP+rFNa 2a is superior to ECP alone in 
including a favornble response in patien ts with advanced cutaneous T-ccll lymphoma as assessed by 
CTCL-S I. Presently, this trend is established in a rnndomizcd prospecti ve multicenter trial. Furthermore, 
CTCL-SI seems va lid in quanti[ying the clinica l course as well as treatment results in patients with 
CTCL. 
P2 
I'CR-BASED DETECTION OF T CELL RECEPTOR-GAMMA REARRANGEMENT 
LN TUMOR STAGES OF CTCL- DIAGNOSTIC VALUE AND LIMITATIONS 
E Djpnel H Schrag M. Hummei:....!:L..SJ&in:. S. Gocrdt C. E. Orfanos 
Department of Dem1atology, institute of Pathology' , Benjamin 'Franklin Medical Center, The 
Free University of Berlin , D-1 2200 Berlin, Gem1any 
Cutaneous T cell lymphoma (CfCL} is considered to represen t a monoclonal T cell 
proliferative disease. In CfCL, monoclonality has initially been demonstrated by Southern 
blotting using T cell receptor (TCR) beta chain probes. Presently, clonality in CfCL is 
una lyscd by PCR of TCR-gamma chain genes followed by temperature gradient gel 
electrophoresis. Using this method, several groups have shown sens itivity for detection of 
clonality to be in the 60-70% range. However, these studies included initial stages ofCTCL as 
wCIJ . To exclude that the low sensitivity was due to minimal T cell inriltrates in early lesions or 
to diagnostic uncertainties, we designed a study analysing 18 patients with a clear-cut clinical 
and histological diagnosis of advanced stage CTCL (c linical stages 11-IV). We employed an 
improved standard consensus primer-based TCR-y PCR method fo llowed by Ouorescencc-
amplified gene scan analysis and sequencing of DNA samples extracted from formalin-fixed 
paraffin-embedded tumor tissue. Of 18 samples tested, 14 showed a c lonal rearrangement of 
the TCR-y chain indicating a sensitivity of only 77%. 'l11is low sensitivity in undoubted C l'CL 
tumors invalidates standard consensus primer-based TCR-y PCR as a reliable tool in the 
diagnosis ofCTCL, especially with regard to early Cl'CL lesions. Currently, we try to improve 
PCR ofTCR to achieve higher sensi tivity rates. 
P4 
PROLIFERATING CELL NUCLEAR ANTIGEN AND SOLUBLE lNTERLEUKI N-2 
RECEPTOR LEVELS IN MYCOSIS FUNCOIDES. 
M Pnwlaczyl¢ V Filnsl M Sobieska;l K. Wiktorowjczl J. Brcborowiczl 
Department of Demu1tology1, Oncologl, Rhcumatologl, University School of Medicine, 
Poznan, Poland. 
Express ion of prol iferating cell nuclear antigen (PCNA) in skin infiltrates and semm levels of 
soluble interleukin-2 receptor (s1L-2R) were studied in a group of 26 patients with mycosis 
fungoides (MF) in various clinicnl stages. The aim of the study wns to investigate a possible 
correla tion between these parameters and activity of the di sease. Skin specimens from patients 
with advanced stage MF revealed the highest percentage of PCNA positive cells compared to 
early stages . The elevated concentration of slL~2R was detected in all of J pnticn ts with 
crythrodcrmic variant of Mf who ulso presented the highest prol ifr.:ration index. 111e median 
va lue of slL-2R level wns higher In patients wi th tumor phase compared to patients in patch 
and plaque stage. No corrc\ation was found between sl L-2R semm level and expression or 
membrane-bound IL-2Ra chain (CD25) on lymphoid cells in sk in lesion. The study indicated 
that PCNA immunostaining and serum s1L-2R level may useful prognostic parameters in MF. 
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LYMPHOMATOID CONTACT DERMATITIS: 2 CASES 
M. Bcylot-Bjlny M S Doutre M Furioli B Vergjer J J>b Merljo C. Bey!ot 
H6pital Haut-IC veque, Pessac, France 
Lymphomatoid contact dermatitis (LCD) is an allergic contac t dermatitis with anntomoclinical 
rcatures close to mycosis fungoides. We report two oddi tional cases: the first in a 58 yea r-old 
female with symmetrical infiltrated erythematous plaques of the pre-auricular areas, the second 
a 84 years-old man with infiltrated plaques of the temples. In both cases, lesions were 3 to 5 
em wide and the rest of the skin was spared. Biopsies showed an aspect of MF with a dense 
lymphocytic infiltrate of the upper dennis associated with epidcrmolropism and marked nuclear 
atypias. These cell s were CDJ+, CD4+ and CD7+. The PCR for the T-cc ll receptor gene 
revealed e ither a polyclonal or on oligoclonal aspect. The first patient noticed that lesion 
appeared after she has changed her glasses. For the second case , the unusual localised aspect 
of <<MF>> lesions and the knowledge of the first case's history led us to suspect a LCD, as 
much as the patient had glasses. Patch tests were positive in both cases with isopropyl-
diphenylenediamine (IPPD) after 72 hours. Biopsy of the test showed an cpidcrrnotropic 
lymphocytic inliltrate associated wi th spongiosis. IPPD is present in n rubber part of the 
glasses: therefore we obtain in the first case a disappearance of the lesion in 2 months with the 
avoidance of the nl\crgcn. "£be fo llow-up of the second case is currently insufficient. 
LCD must be confused with MF, as in our second case that has been treated by elcctronthcrupy 
before diagnosis. Indeed, infiltrated plaques, histological nspect arc very closed to Mf. 
However, localised skin lesions, as the presence of spongiotic foci must Jed to suspect LCD and 
to investigate patients with patch tests. Only one case of LCD has been studied by PCR in 
literature and was polyclonal for the TCR gene areas as in our first case. However, this is not a 
forma l argument for the benignity of this prolirerntion. 
P3 
CONTRIBUTION OF ffiSTOPATHOLOG ICAL AND MOLECULAR ANALYSES TO 
THE DIAGNOSI S O F CUTANEOUS B-CELL rNFIL TRA TES. 
~ B. Vcrgic~ M. Beylot-Ba~ M.M. De!aunnf J.F. Gou.ssot1~1 A de f1n scare\1~ J . . Ph. Mcrlio1 
Departments of Pathology, Histo logy, Dermatology, CHU of Bordeaux and Uni ve rsity of 
Bordeaux 2. Bordeaux and Pcssae Fmnce. 2 Department of Immunology, lnserm. CHU Henri 
Mondor. Crl:teil. 
To evaluate the va lue of morphological , immunohistochemical and molecular una lyses, we 
have studied 2 1 skin biops ies from 19 patients with primary cutaneous B-cell infiltrates. 
Morphological review by two independent dermatopathologists allowed the consensus 
diagnosis o f lymphoma (n=6) or benign lymphoid hyperplasia (n=6). A discordant diagnosis 
was made for the other samples (n=9) thereafter considered as unclassified lymphoid infiltrates. 
Immunohistochemistry showed e ither a rnonotypic express ion of immunoglobulin light chain 
or n posi tive staining with anti-bcl-2 antibodies in respectively 3 and 4 samples of lymphoma. 
Polymerase chain reac tion (PCR) w:~ s used to ana lyze immunoglobulin heavy chain <J nd T-ce\1 
reccptory chain gene rearrangement and to amplify t(14;18} and t(l l ; l4) breakpoints. A clonal 
molecular marker was detected in 12 ou t of 19 patients. Among these 12 patients1 final 
diagnosis of lymphoma was confirmed in 8 patients including the 6 patients with morphological 
diagnosis of lymphoma. Two patien ts with clonal benign lymphoid hyperplasia and 2 patients 
wi th clonal unclass ified lymphoid infiltrate presented a benign cli nicnl outcome and one was 
lost. 
Alternatively, no clonal molecular marker was found in two cases of lymphoma. When two 
pathologists agree fo r the diagnostic of either malignant or benign lcsion1 molecular analyses 
are of limited interest fo r the diagnosis. When the lesion is unclass ified or when 
histopathological review is discordant, the detection of a clonal lymphoid population should 
lead to the follow-up of pa tients at risk for lymphoma. 
PS 
LACK OF TL-7 mRNA OVEREXPRESSION IN MYCOSIS FUNGOJDES. 
K Asad ull ah A. Hncu!3\cr M Friedrich A, Siegling S. Olaizo ln- Hom U. Trcfzer H D.Volk 
~
Departs. of Dermatology and Immunology, University Hospital CharitC, Berlin, Germany. 
lntcrleukin 7 (IL-7) is thought to ben growth factor for cutaneous T cell lymphoma (CI'CL) 
since it has been shown that a) IL-7 transgenic mice developed a cutaneous disorder 
characterized by enhanced T ce ll proliferation with progression to malignancy and b) in vitro 
growth of SCzary cell lines was fL-7 dependent. However, no direct in vivo evidence exist for 
the involvement of lL-7 in the pathogenesis of CTCL. Therefore, we examined IL-7 m.RNA 
expression in skin biopsies from patients with CTCL such as mycosis fungicides (MF) (n=20) 
or pleomorphic T-ce ll lymphoma (n=5). By competi ti ve RT-PCR IL-7 m.RNA was neither 
de tectable in ony of the CfCL samples nor in normal human sk in (n=8) or skin from pa tients 
wi th psoriasis (n=7) or atopic dem1atitis (n=5). ln contrast, lL-7 mRNA could be detec ted in a 
biopsy fTOm a kidney allografi transplant, nonnol kerntinocytes under various culture 
conditions and several cell lines. Interestingly, using a highly sens itive nested PCR, lL-7 
mRNA was detectable in all specimens tested, but there was no indications of IL-7 
overexpression in CI'CL when ana lysing patch, plaque, and tumor stage MI=-. In contrast, 
increasing CDJ expression was found which is most likely due to the enhanced density of 
malignant T-eclls in advanced tumor stages. ln summary, by using competitive RT-PCR we 
cou ld not detect JL-7 overexpression in CfCL. This indicates that JL-7 is probably not an 
autocrine growth factor in MF. 
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EXPRESSION OF EGF, EGF RECEPTOR, AND TGFa IN CUTANEOUS T CELL 
LYI'IIOMAS WITH PSEUDOTUMORAL EI'IDERMAL HYPEIU'LASIA. 
P. Courville J. Wechsler E. Thominc Y. Fonck 8 Vergier M. Barry-Beylot M. Bngot P. 
Souterrand P. Jolv French Study Group on Cutaneous Lymphomas 
C liniquc Dennatologiquc: HOpital Charles Nicolle in Rauen nnd Dijon, H6pital Henri Mondor 
Creteil , France 
The clinical and histological features of II cases of cutaneous T-cclllymphomas (CTCL) with 
pseudo tumoral cpidcm1al hyperplasia (PEH) arc reported. The express ion of EGF. EGfr and 
TGFa wns eva luated by immunohistochemistry and compared to I 0 cases of CTCL without 
PEH. The cases of CTCL with PEH consisted of 8 of the 28 CD30+ CTCL (29%) and 3 of the 
148 Mycos is Fungoides (2%) reg istered by the group from 1990 to 1995. Epidermal expression 
of EGF, EGFr and TGFa was stronger in CTCL than that observed in normal human skin. 
Surprisingly, lymphomatous T·ccll s from CTCL with and without PEH expressed EGF and 
TGFa., whereas no ex.press ion of these cytokines cou ld be detected in 5 control cases of B·cell 
lymphoma. No difference in the epidermal expression of EGF and TGFa could be evidenced 
between C r CL with and without PEI-I. ln the contrary, the expression of the EGFr by the 
keratinocytes from CTCL with PEH was stronger than that ofCl'CL without PEH . Our results 
suggest that lymphomatous cell s of CTCL produce EGF and TGFa. An EGFr hypcrcxpress ion 
by the overlying epidermis may explain the PEH seen in some cases of CTCL. 
P8 
ANTIGEN-DRIVEN CLONAL EXPANSlON OF 8-CELLS fNFILTRATING 
SALlY ARY GLANDS AND LYM.PH NODE TISSUE .IN PA TlENTS WITH 
SJOEGREN'S SYNDROME. 
S. Gcllrich A. Borkowski~ S. Golcmbowski S. Rutz E Gromnica-lh le! .. W. Sterry S. Jahn 
Department of Dermatology, Medical faculty (CharitC), Humboldt· University Berlin and 
11RJ1cuma klinik Berl in-Buch, Berlin, FRG. 
ln Sjocgrcn 's patients, 0 cells were found to in.liltrate salivary glands resulting in sialudcnitis 
and kcrotokonjunctiviti s (Sicca syndrome). Early in the di sease course a monoclonal 
gamruopathy is detectable in sera of those patients and the frequent occurrence of B-cell 
malignancies was reported. 
To analyse in more deta il the V11 gene rcpcrloire expressed in B cells infiltrating salivatory 
glands and lymph nodes in two Sjocgren's patients biopsies were taken, mRNA and eDNA 
were obta ined and the immunoglobulin V11 gene rearrangements were amplified using specific 
primers for the FlU region (V11) nnd the J11 or the CHI domain gen segments. A total of 137 
V11DJ 11 transcripts were cloned and ::;cqucnced. Suggesting from sequence analyses the B-ce\1 
infiltrates in all tissue specimen were of polyc lonal origin. Nevertheless in both labial sali vary 
gland and lymph node biopsies the expansion of a number of 8-ccl\ clones became evident 
'111c V11 DJ 11CHl y transcripts obtained by PCR suggest that these clones produce lgG 
antibodies. The ana lysis of the mutational pattcm indicated the matumtion and expansion of the 
8-ccll s in the resu lt of antigen stimulation . For one individual clone, an ongoing mutational 
process was documented. Members of this clone ha ve been found both in the lip and lymph 
node material sugges ting an emigrntion nnd circulation of these B cells, wilhout histologica l 
evidence of a developing lymphoma. 
Our data provides further evidence that a clonal B~ce ll expansion under antigen stimulation 
takes place in sali vary glands of Sjoegrcn 's patients. It may be speculated that those B-ee\\ 
clones durin g disease progression may expand resulting in lymphomagenesis. 
P10 
PRIMARY CUTANEOUS T-CELL-IUCll 8-CELL LYMPHOMA EVOLVlNG INTO 
HODGKIN'S DISEASE IN A I'ATIENT WITH GAJIDNEJ!'S SYNDI!OME 
J. Kamarashcyl R. Dllmmcr-1 M. Hess1 T. Frit7.\ M. Kurr
1
crl ~ 
Department of Dcrmatolgy1 and Department of Pathology , University Hospital ZUrich 
A 50-year-old patient was rciCrred to the Department of Dcmmtology in ZUrich for the 
evaluation of several nodules of slow evolution, si tuated on the curer aspect of hi s lc ll ann. 
Histo log ical examination revea led a dense demml infiltrate consisting predominantly of small 
lymphocytes and a small number of large p leomorphic cell s. lmmunophcnotypisatiou revea led 
the predominant small lymphocytes to be T-cclls, while the fewer large cells expressed B-ce ll 
markers (CD20+;CD30-). Routine staging procedures failed to detect any systemic 
involvement. The diagnosis - primary cutaneous T-ccl l-rich B-cclllymphomn was established. 
Tite lesions were excised and the patient was fo llowed up regularly. Three years later enlarged 
lymph nodes in his right axi lla and a significant splenomegaly were detected. Histological and 
immw10histochemical examination revealed a lymphocyte predominant infiltrate with large 
cells of typical Reed-Sternberg cell morphology, which were CD30+ CD20-,rcsulting in a 
diagnos is of Hodgkin 's disease. l)rimury cutaneous T-ccll -rich B-cell lymphoma is an 
extremely rare entity . The two previous ly reported cases with fo llow-up suggest benign course 
of this variant. Our case however suggest that systematisation with shift to Hodgkin 's disease is 
another possible outcome. 
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MYCOSIS FUNGOIDES WITH EPIDERMAL NECROSIS. 
P. Courvi lle~ S. Dnlacl E. Thomincl T Petrella± J Wechslcr1 
Departments of Dcm1atology, Charles Nicolle Hospital Roucn 1, Henri Mondor Hospital 
Crcteils, Dijon Hospitn\4; French study group on cutaneous lymphoma in Charles Nicolle 
Hospital Rauen and Dijon Hospital1 
TI1e clinica l and histological features of 3 cases of Mycosis Fungoides (MF) with cpidcmml 
necrosis arc reported. After a several year follow-up period of plaque stage MF, an 
crythrodcnna with numerous and disseminated superficial skin erosions occurred in the 3 
c.ascs. His tologi cD l cxaminatlon of the ulcerative lesions showed a dennal infiJtrate of Stzary 
cells, numerous necrotic keratinocytcs and epidermotropic atypical lymphocytes. 
Lymphomatous cells were C04+ CDS- in all cases. Th~: expression of TNFa. and apoptosis 
marker was evaluated by immunohistochemistry using anti-TNFa MoAb and cell death in situ 
labeling and detection system ApopDETEKTM_ In the 3 cnses, no expression of TNFa nor 
apoptos is marker could be evidenced. One to 3 month after the onset of erosive lesions, the 3 
patients died, of an cxtracutaneous di ssemination of the MF in one patient, or of infectious 
complications in the two others. In conclusion, this rare and particular form ofMF, 1) seems to 
be associated with a poor prognosis and 2) raises the ques tion about the mechanism o f the 
epidcm1alnccrosis. 
P9 
l'lLOTROI'lC SKIN INVOLVEMENT IN LOW-GI!ADE 8-CELL LYMPHOMA 
~l~~l~~~~.!. B LenomJand!..l.. 
 ~1. J C Gui!lnumc1.....r....12..land the french Smdy Groun On 
Cutaneous Lymphoma 
1 Colmar, 1 Strasbourg, 1 Villcjuif, • Rauen, ' Crctcil, France 
Papular or papulo-ves icular erupt ions of uncertain nature have been reported during tl1c course of 0-ccll 
chronic lymphocytic lcukcmin (B-GLL) or l ow~grade 13-cc\l lymphoma (LGBCL). We describe five 
patients with a disti nctive eruption consistent with pilotropic skin involvement in LGBOL. 
Ctzses: One rnalc patient with a B·CLL and four male patients without known lytnphomrl or leukemia 
(mean age: 71 years; range: 51 to 79) h3d cutllncous lesions occurring mainly on the face for one month 
to four years (median: 6 months). Acn·e nccrotka, rosacea, herpes and insect bites had been previously 
suspected. Lesions were rccurrc/11 or pcrsiswnt papulo-vcsicl ~s of papu les with frequent central 
ulceration. Skin biopsies showed a pilotropic lymphocytic inliltratc in all cases and and piloscbn.ccous 
necrosis in four cases. Specific stains for mucine were negati ve. hnmunohistochemicol studi es showed a 
CD4+ T-cc ll infiltmtc with few D-cc lls (three cases) or on admixture of B· ond T-ccl\s (two cases). 
Atypical B-cells consistent with lymphoma were only seen in one case. PCR analyses showed n 
rca!Tllngcment of the immunoglobulin heavy-chain gene in 3 of 5 cases and no rearrangement of the T-
ccll receptor gene. 
Investigations for the presence of a LGBCL were posi tive in all cases: three patients h:~d a foll icle ccmre-
celt lymphoma im•olving the nodes (two cases) or limited to the skin (one case). One patient had a non 
leukemic lymphocytic. 13-ccll lymphoma with lymph nodes and bone marrow involvement . One patient 
had a B-CLL. After various courses of chemotherapy and a mean fo llow· up time of 22 months (mnge: 
II to 34), two patients achieved a complete response with resolution of cutaneous lesions, one patient 
who hnd a stable LGBCL continued to have recurrent papulo-vesicular lesions, and two patients who had 
a progressive disease developed skin nodules or tumors. 
Discussion: 'l11esc findings are suggest ive of a pilotropic skin in vo"•cment in LG BCL associated with a 
marked T·ccl\ reactive infiltrate. Recognition or this characteristi c: eruption may lead to an early 
diagnosis and treatment of the associated hematologic disease. 
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EXPRESSION OF ADHESION MOLECULES ON ENDOTHELIUM IN l'lVO IN 
PATIENTS WITH ERYTHUODERMA. 
V. Sigurdsson J I.M . de Vries J Toon!Hra I C Bihari C.A.F M. Bnlljnzcc i-Koomen T. 
'n1cpcn W.A. VO'ln Vlotcn 
Department ofDcm1atology and Allergology! Un iversity Hospital, Utrecht, TI1e Netherlands 
Erythrodcnna may result from different causes. At present it's unclear whether the patho-
mcchanisms that lead to these different types of erythroderma arc identical or different 
Ad hes ion molecules and their ligands play a major role in endothelial-leukocyte interactions 
which affect the binding, tra nsmigration and infiltra tion of lymphocytes and mononuclear cell s 
during inflammation, injury, or immunolog ical stimulation. '111e aim o f this study was to 
investigate the adhes ion molecule express ion on endothelia l cells in erythroderma in vivo. 
A total of 42 snap-frozen skin specimens were used in this study. Twenty-two from patients 
wi th erythroderma (8 idiopathic erythroderma, 5 crythrodcrmic atopic dcm1aticis, 3 SCznry 
syndrome and 6 crythrodcm1a from miscellaneous causes), tO from patients with mycosis 
fungo ides, 5 atopic dermatitis, and 5 healthy volunteers. 
The biopsies were immunohistochcmically double stained with biotinylatcd Ulcx Europaeus 
agglutin I as a pan~cndothc\ial ce ll marker. and for the adhesion molecules VCAM-1, ICAM· l , 
E- and P-se lectin . All doub le· and single-stained blood vessels in the dem1is were counted. 
Mean endothe lial express ion in erythroderma was: VCAM- 1 49.3% , ICAM· l 68.9%. E-
sc lcctin 42.3% and P-selectin 50.4%. 1ltcre was no stati stical difference between di ffe rent 
groups of erythroderma. Mean expression in SC7.ary syndrome was higher than by mycosis 
fungoidcs albeit not statistica lly significant. In erythrodemlic atopic dermatitis only VCAM- 1 
express ion was s ignificant higher than lcsional skin of atopic dcnnatitis. 1l1e other three 
adhesion molecules did not show this diffCrence. 
We conclude that endotheli al expression of adhesion molecules in SC.zary syndrome and in 
benign reacti ve erythrodenna docs not differ from each other. 
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LYMPHEDEMA-AREA RESTRICTED LYMPHOMATOID PAPULOSIS 
L Va illant A de Murct L Martjn V Jan G Lorette and the French Stydy Groun 
DCp3rtcmcnt de Lymphologic ct de Dcrmntologie, CHU TOURS, France 
We report a case of lymphomatoid papulosis strictly localised on an ann wilh lymphoedema. 
Case report. A woman born in 1920, suffered in 1983 from lefi breast adenocarcinoma. She was treated 
by masteetomy wi lh ax illary lymph node dissection, local and regiona l radiotherapy. 1l1e left arm was 
affected by lymphoedema in 1988. In 1995 some firm erythematous, occasionally angiomatous, not 
pruriginous, papules appeared; their size was 2 to 10 mm. We also noticed few nodules; one of them was 
necrotic. All lesions waxed and waned and were strictly localised on the lymphocdcmatous areas (arm, forearm and wrist). The patient was hospitalised to rule out Stewart· Treves angiosarcoma or cutaneous 
metastases of breast adenocarcinoma. Microscopic examina tion of a biopsy specimen of a papule 
diagnosed lymphomatoid papulosis, because of diffuse dermal infiltrate composed of few large C030+ 
atypical lymphocytes mixed with inflamm:.tory cells (numerous small lymphocytes and some ncutrophils 
and cosinophils); some degree of cpidennotropism and frequent mitosis were seen. 111ere were no 
lymphadenopaties. Chcst·x-ray and abdominal cchography were normal. A treatment by dermocorticoids 
was given and no recurrence occurred during 5 month follow·up. 11JCn a relapse occurred that was 
treated by ora l prednisone whic h led to a complete remission. 
CommetJts. 111e lymphomatoid papulosis was diagnosed in our case because the patient had tJu: usual diagnostic cutaneous criteria of this di sease: 1) mutiple papules and nodules, 2) spon taneous regress ion 
of d1c lesion followed by recurrence, 3) no les ions greater than 3 em, 4) no lymphoedemotous areas, no 
systemic involvement, 5) presence of atypical lymphocytes. Our case is very unusual because the lesions 
were restricted to the lymphomateous areas. This unusual localisation of a generalised disease seems not 
co incidenta l. OU1cr cutaneous diseases restricted to lymphoedema-area were prev iously reported, 
paticularly Sweet syndrome, bullous pemphigoid, Ki· l large cell cutaneous lymphoma.' ln these cases the 
chronic immunodcprcssion induced by lymphoedema may be the cause of the dermatosis. l11is case was 
also remarkable for the clinical aspect that may be a differentia l diagnosis of Stewart·Trcvcs 
angiosa rcoma. 
P14 
8-CELLLYM.I'IWMA MALIGNUM IN STADIO lv'. 
J. Eicdorowicz 
Dcnnatology C linic, Pomeranian Medical Academy, Szczccin, Poland. 
A 40-ycar·old male patient developed a year ago infiltrated plaques on hi s arms and on 
extensor s ide of thigh. 7 months later tumor lesions in the area of the infiltrated plaques 
appeared. 
Immunocytochemical examination revealed the lymphoma malignum of large B-ccll 
lymphocytes origin (CD20+, CD30-, UCHL·l). Fraction of the tumor growth determined by 
applying MJB 1 antibody was 50%. ln the blood smear a numerous lymphoid cells were found. 
Patient was qualified for cytostatic treatment. 
P16 
SEZARY SYNDROME (SS). A DESCIUPTIVE STUDY OF 29 CASES. ~1 T. - ~s~ra chz. J Go~z{tlczl M. fo¥i!.!6n1~l...Ji,_Eui2.t1· J. Mirallc~.l~ ~ ~ F. <;Ja ll ard_o~ ;' Rom.agosa ~. . ~ . University Llcida , Hosptta l C hmc , HospHal S. Pau , Hospttal Bcll vttge , Hospttal Mutua de 
Tcrrassas; 13arcclona. Spain. 
C linical, histopathological , immunophenotypical and immunogcnotypica l features of 29 cases 
of SS from 4 Dcnnatology Departments of Barcelona were reviewed. 18 patients were males 
and 11 fema les wi th a mean age of 66 years (range: 37-90 years). A medical history (from 2 
month to 23 years), of "eczematous dcnnatitis" was recorded in nil cases. 7 patients hnd a 
previous d iagnosis of parapsorias is/mycosis fungo ides. One patient was under cyclosporine 
therapy because of a heart transplantation . All, but 6 patients, presented with erythrodem1a at 
SS diagnos is. Adenopathy and pururitus were constant symptoms. Severe lymph node 
involvement (LN3/LN4) was detected in only 15% of cases and visceral infiltration in 20%. 
Chlorambucil + prednisone was the first treatment in about 50% of patients. Most patients 
received more than two different consecutive therapeutic reg imes which included 
polychcmotherapy, alfa-intcrfcron, extrocorporeal photophcrcsis, methotreaxte, ctretinate, etc. 
Partial or minor remission were the most common response. Only 3 patients nrc in complete 
remission at the end of the study. Median fo llow·up was 2 years (range: I month - 9 years). 17 
patients died, most of them because of septic complications. Most cases were characterised by 
epidem10tropic dermal bandlike lymphoid infiltrates. Well performed Pautrier microabscsses 
were seen in only 50% of skin specimens. Predominance of blastic-large cells, high 
proliferation rate, granulomatous infiltrates and follicular mucinosis were rare phenomena. 
Presence or eosinophils and plasma ce lls was variable. Neoplastic cells showed a helper T-ccll 
phenotype with occas ional loss of mature T cell antigens. Secondary CD30+ lymphomas were 
not detected. Immunogenetic studies, done on peripheral blood and/or skin spec imens of 9 
patients, demonstrated monoclonality. 
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THE BIOLOGICAL EFFECTS OF VIT. E IN I'UVA TREATED CELLS. 
I M Schmitt E Camera C. Mordenti M. Picardo S. Chimcti. 
Departments of Dcnnatology, University L'Aquila, San Gallicano Dermatological Institute 
Rome, Italy_ 
PUVA therapy and cxtracorporcal photochemothcrapy (photophcrcsis = EcP) arc well known 
therapeutic modalities for the treatment of a series of cutaneous disorders. Although the 
immune modulating effect of PUV A is thought to mainly arise from DNA damage and 
induction of transcription factors, its release has been postul ated to be co·initia ted by photo 
induced cellular membrane damage. As prev iously shown, the impact of PUV A treatment 
induced a reduction of intracellular levels of Vitamin E, inhibition of catalase activity and 
peroxidation of polyunsaturated fatty acids to a variable degree, in a time and 8·MOP/UV A 
dosage dependent fashion. Jn thi s study, we investigated on Vitamin E and its possible role in 
the prevention of the ox.idative damafe induced in a lymphomatoid murine cell line {R.MA) 
ufier 0, I 0, I 00 ng!ml 8-MOP+ JJ/cm UV A treatment. lllc addition of Vitamin E to the cell 
cu lture medium 6 hours prior to PUVA, led to significant enhancement of intracellular levels 
of Vitamin E in treated as well as in untreated cells. Also, a reduction of SO% in the 
pcroxidation pattern of unsaturated fatty acids us well as reduction of 15% of cata lase activity 
after PUVA was observed when compared to controls alre<tdy at time 0. Under the same culture 
conditions, at 24 llfs, an increase of the pcroxidativc damage could be seen. In contrast, the 
add ition of Vitamin E immediately nfler PUVA treatment was able to completely recover 
intracellular Vitamin E levels and c<J talase activity aflcr 24 hours, whereas pcroxidation of 
polysaturatcd fally acids was evident at the time of PUV A treatment and rcnmincd pcroxidatcd 
also after 24 hours. In conclusion, Vi tamin E pre· and post treatment is capable of revers ing the 
oxidative damage induced by the phototoxicity of PUVA and should be considered when 
PUV A/EcP is therapeuti ca lly associa ted with antioxidants. 
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CUTANEOUS INTOLERANCE TO MECHLORETHAMINE IN CUTANEOUS 
LYMPHOMAS: A PROSI'ECTIVE STUDV OF 43 PATIENTS. 
E. Esteve M. Bagot P. Joly P Souteyrand M. Bcylot-Banv L. Vaill ant M Dclnunny M.F. 
AVTi l L. Laroche F. Gr;mge E. 1l10minc l Wechsler 
·n1e french Study Group of Cutaneous Lymphomas-France 
Mechlorethamine hydrochloride is a cost-effective and convenient treatment of cutaneous T-
cell lymphomas. We carried a prospective study from 1•1 January 1996 to 3 1 May 1996 to 
precise the exact frequency and the histo logical features of cutaneous into lerance to 
mechlorethamine. This series included 35 men and 17 women, aged from 18 to 87, with 
Mycosis F ungoidcs (35/52), non epidcrmotropic cutaneous lymphomas (8/52), Lymphomatoid 
Pnpulosis (7/52), Sezary Syndrome ( 1/52) and Lnngerhans Histiocytos is (1/52). 43 patients 
were eva luable at the end of the study. Patients with cutaneous reaction to mechlorethamine 
were patc)Hcsted and cutaneous biopsies of the pos itive tests were perfonncd. Cutaneous 
intolerance occurred in 23/43 (53%) patients, from 4 days to 9 months uflcr the onset of 
treatment (mean= I .6 month) . It occurred within I month in 13/23 (56%) and within 3 months 
in 21 /23 (9 1%). Patch·tests were performed in 21/23 patients and were positive in 12/23. 15 
biopsies were pcrfonned and reviewed by 2 pathologists. Histologica l features were consistent 
with eczema in 10/15, irritative dennatitis in 2/15 and non significative in 3/15. We conclude 
that nllcrgic dermatitis to mechlorethamine is a fast and frequent adverse reaction in patients 
with cutaneous lymphomas. 
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I'ARAI'SOIUASIS IN I'LACIBUS l'ROIIAUlLITER TOXICA I.N T CJCLL 
LYMI'EIOMA CUTIS VEilTENS 
A. Nowak L. Za lewska·Kubjcko K. Turck-Urasinska B. Si'.amer D Miku lskn 
Department of Dermatology, Pomeranian Medical Academy, Szczccin, Poland 
We present three cases of cutaneous T cell lymphoma in the workers employed for about 20 
years in the manufacturing textiles industry. Case L - A 45 years old fcmnle, has been 
suffering from the skin itching for ten years. In 1985 desquamative, erythematous, hemorrhagic 
foci appeared wi U1in the skin of annpits and groins, corresponding to large plaque 
paropsorios is. The patch tes ts to formaldehyde, benzidine and sodium sulphate were positi ve. 
Case 2. - A 42 years old female. In 1986 a skin itching had started, then in 1987 the rash of 
poik:ilodcnnic chnrncter appeared on the sk in of the face and the neck. The rash sprayed to her 
armpi ts, upper extremities, groins nnd lower extremities. ln 1996 the hair falling out was stated. 
The allcrgologic patch test were negative, the photo patch test wus positive. Cnse 3. - A 64 
years old male. In 1976 the dryness und itching of the skin had appeared. Ten years later hair 
falling out wus also found. In 1996 the erylhcmnto·dcsquamativc foci were recorded in the 
reg ion of clavic le on the len s ide and on lower extremities. The patch tests were negative. The 
diagnose of CfCL in cases l , 2 and 3 was proved histopathologica lly - standard hi stochemical 
methods as well us immunohistochemical techniques employing monoclonal antibodies were 
used. 
VOL. 109, NO.3 SEPTEMBER '1997 
P18 
THERAPEUTIC ALGORITHM IN MYCOSIS FUNGOIDES 
M Pawlaczyhf r Rumi;s.owski~ M Knzmicrowski1 C Rnmlaul M. Bowszyk-
Omochowska J Brcborowic , 
Department of Dcnnatology1, Oncolog/, University School of Medicine, Pozan, Poland 
TI1c treatment of mycosis fungoidcs is a therapeutic challenge. The aim of this study was to 
evaluate the effectiveness of different therapeutic meU10ds used according to the clinical stage 
of the disease. Treatment results were analysed in a group of 52 patients aged from 21 to 81 
years, treated during 1980- 1997. Early-stage disease was treated with topical chemotherapy 
and photochcmothcrnpy. Loca l application of nitrogen mustard so lution produced the complete 
clearing in 5 of 7 patients, lasting for more Umn 4 years in three of them. Photochemotherapy 
was used in 31 subjects and resulted in complete and partiul remission in 71% and 19% 
respectively. ln the case of relapse, PUVA was combined with administration of ctretinatc or 
prednisone and radiotherapy. Patients with advanced disease or therapeutic failure were treated 
with systemic chemotherapy. Combination chemotherapy was app lied to 15 patients and the 
complete or partial response were achieved in 80% with median duration of remission lasted 
for 3.5 month. Summarising the management in presented !,'TOUp of patients, we found median 
survival rate of8.2 years (ranged 3.5 to 14}. 
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CUTANEOUS T-CELL LYMI'HOMAWITH HISTIOCYTIC CYTOPHAGIC PANNICULITIS 
(HCP): 2 CASES 
~M i c.<;sa n n. ! cjhnwjteh!~l~!~~~J. 
and The french Study Qroun On Cutnncous l ymnhoma,s 
1 Department of Denniltology, HOpitu l Tnmicr·Cochiu, • Dcpanmcnt of Anatomopatho logy, HOpital 
Cochin, 1 Department of Dennatology, H6pital Saint· Louis, Paris, France 
Patient I: A 27·ycar old woman had ulccrnted nodules of legs and trunk. Oiopsy showed a 
lymphohistiocytic lobular panniculitis. Two years lt~ter, biopsic revealed a HCP. 3 months later, she 
presented with fever, diffuse nodules, splenomegaly, pancytopenia. rnised liver enzyme and LDI·L 
Cutaneous biopsy showed a peri vascular infiltrate of pleimorphic large atypica l lymphocytes (with 
clonality for the T -cell receptor). A medullary hcmophagocytohistiocytic infiltrate without 
lymphomatous involvement was observed. Remission was achieved with polychemothcrnpy. She shortly 
rclo:Jpsed and died of sepsis. 
Patient 2: A 66·year o ld woman had nodules of legs. Biopsy showed n lobu lar infiltrate of norn1a l 
histiocytes. Six month 1nter, she presented with diffuse nodules, raised liver enzymes and LDI·I. Diopsy 
showed a HCP and n dense subcutaneous infiltrnte of large atypical lymphocytes CD3+, CO&+, without 
evidence of EDV express ion. An isolated increased number of histiocytes wns observed in bone marrow 
and li ver. She died of sepsis. Autopsy rcvcolcd no histiocytic and lymphomatous infiltration. 
Twenty·two cutaneous T·celllymphomas with HCP have been reported. 11Je subcutoncous and dcmml 
infiltrnte is more ofien composed by large·size CD4+ lymphocytes. No ex.tracutancous involvement has 
been shown. Hemophagocytic medullary infiltmte is often present. Sixteen patients died (72%) of 
hemophagocytic syndrome, sepsis and intravascular disseminated coagulation. Repeated biopsies arc 
often needed because of the initial non specific ltistologic pattern of these panniculitis. HCI, may prcceed 
the appearance or lymphoma. Patient 2 raises the value or an isolated incrcosed number or histiocytes as 
a first sign of HCP ancVor hemophagocytic S}'lldrome. 
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PIUMARY CUTANEOUS CDJO (Ki-1) POSITIVE ANAl'LASTIC LARGE T CELL 
LYMI'HOMA ASSOCIATED WITH RENAL T CELL CARCINOMA: LITERATURE 
IIEVIEV OF 87 I'ATIENTS 
S.A.A. Shah A. Husa in: A.D. Onnerod 
Departments of Dcm1atology and Patholgy, Aberdeen Royallnfinnary, Aberdeen, U.K.. 
We report a case of primary cutaneous CD30+ Anaplastic Large T Cell Lymphoma (ALCL) 
;:~ssociatcd with renal T cell carcinoma. The incidence of renal carcinonm is higher in 
association with lymphoid malignancies than in nonn;:~ l population. 
A 43 year o ld man developed a tumor on the right upper lib over 6 months which was excised. 
No palpable lymph nodes were detected and systemic examination was nom1al. Histology 
confim1ed a CD30 + ALCL of null T cell type. Staging revea led a mass in the lcfi kidney 
which proved on nephrectomy to be clea r cell renal cell carcinoma. There was loca l recurrence 
of the lymphoma at 8 weeks which resolved with chemotherapy (CHOP). 
Systematic review of 87 patients in the literature was carried out, 58 were male, 29 female. 
Cell type was T cell in 82, null cell in 5 and none were B ce ll . Below arc treatments and 
recurrences (56.3% overall) in parentheses: Excision 35 (18) , chemotherapy 20 (13), excision 
and radiothcrupy II (7), radiotherapy II (4), chemotherapy and radiotherapy 3 (3), no 
treatment 7 (4). 65.5% arc alive and we ll , 11.5% alive with disease, 10.3% died of disease, 
12.9% died of other causes, median survival was 38 months . Deaths occUlTed in 3 uner 
cx.cision, 4 aner chemotl1crapy and 2 nficr chemotherapy nnd radiotherapy. 
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TREATMENT OF AOULT-T-CELL LEUKEMIA-LYMI'HOMA (ATL) WITH ZIDUVOD!NE 
AND INTERFERON ALPHA (I.FNa): 3 YEARS FOLLOW-UP OF 2 I'AT!ENTS WITH 
UNUSUAL CUTANEOUS FEATURES. 
~ M 1 ess;ma.l ejbowjtcb!~l~l~ondTheFrnnchStudy 
Group on Q,Jtnncous I ymphomas 
1 Department of Dcnnatology, HOpital Cochin·Tamier, 2 Department of Hnc.matology, HOpital Cochin, 
Paris, France 
Both patients initially presented with papules (sarcoidosis·likc, molluscum contagiosum·likc), 
lymphadenopathy, nonnal LDH and ca lcium levels. 
11tey were seroposit ive for HTLV·I which clonal integration was demonstrated (blood, skin). Biopsies 
revealed a dermal infiltrntc of atypical lymphocytes with cpidem10tropism, specific infiltrate of lymph 
node, no bone marrow involvement. 
Patient I was ll 40 year·old bulgarian woman with ATL·lymphomntous type. A one year old complete 
remission was ach ie\'ed afler 3 monlhs of zidovudinc (500mg/d) and J.FNa (9 MU/d). An ncutc type 
relapse appeared 3 months afler stopping treotment: 60% leukemic cel ls of 34.10' lcucocytes!L, diffuse 
involvement, hypercolccmia and raised LDH level. Leukemic cells persisted despite clinica l remission 
with zidovudinc ( lg/d) and LFNa (9 MU/d). She died 6 months later despite combination chemolhernpy. 
Patien t 2 is n 27 year-old carribean man with ATL·ocute type (55% leukemic ce lls of 27.109 
leueocytesiL). 4 months aflcr zidovudinc (l gld) and IFNa (9 MUid) clinical features disoppeared, 
leucocyte count was nonnol with 5% of atypical lymphocytes. On haJf.doses therapy, remission is 
mnintained 3 years later, with 5 to 10% atypical lymphocytes. 
In acute and lymphomatous types, median surviva l ranges frpm 6 to 10 months desp ite various 
treatments. The combination zidovudine--IFNa allowed a remission lasted respectively one year (patient 
I) and at least 3 years (patient 2). Although the mechanism of action of this combination is unknown, the 
benefit of adjunction or combined ::a ntirerroviral drugs to IFNa in ATL could be raised. 
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INTIIALESIONAL C ISPLATlN-EPINEI'HRINE-COLLAGEN GEL FOR THE 
TIIEATMENT OF CUTANEOUS B-CELL LYMPHOMA 
W Kempf G. Burg D M. Hill: R. Dummer 
Department of Dcm1atolgy, University Hospital Zurich, Zurich, Switzerland, "Matrix 
Phannaccuticnl, L TO., Hnnts GU34 2QJ U.K. 
Because C BCL is a rJrc disease, there arc no generally accepted standards for the treiltmcnt of 
primary cutaneous B-ccll lymphomas. Experimental and first clinica l trials indicate that 
intratumoral injected cisp latin in ,n collagen·cpinephrine gel is a new potent local chemotherapy 
for various tumors, especia lly in head and neck cancers. Cisp latin gel is a three component gel 
system consisting of a collagen gel con taini ng cisplatin (4 mglml) to nvoid rnpid diffusion of 
cisplatin in tumor environment and circu lation. 
We report on a 56· wear-old white women presenting with a primary cutaneous follicular center 
B·ccll lymphoma on the scalp. We injected once per week 0.5 to 1 ml of the cisplatin 
containing gel (lntrnDoscTM Cisp latin/Epinephrine injectable ge l, MPI 50 10, Matrix 
Phannaceutica l, Inc., Fremont CA 94555) into three of totnlly four tumoral nodules over a 
period of five weeks. Aflcr the third injcction1 the tumora l lesions became demarcated and 
necrotic . After two months the necrotic tumor mass could be removed wi thou t surgic::t l 
intervention or anaes thesia. Five months later, no recurrences of lymphoprolifcrativc 
infiltrations could be detected on follow·up. 
Treatment of cu taneous lymphoma with topically applied cisplatin has not yet been reported. 
This case report demonstrates the successful usc of topically admistcrcd cisplatin·cpinephrine· 
gel as an altemative therapeutical approach for primary cutaneous B·celllyrnphomns. 
P23 
IO.ENTIFICATION OF NATURALLY PRESENTED TUMOUR ANTIGENS OF 
CUTANEOUS LYMPHOMAS 
T . Linnemann C Brock K Sparbicr K. Kr~ltofl • W . Sterry P. Wnlden 
Department ofDcm1atology, Medical Faculty CharitC, 
Humboldt University, Berlin, Germany 
• Department of Human Genetics, University of Aarhus, Denmark 
MHC class l·bound pcptides were extracted from cuhurcd cutaneous T cell lymhoma and 
fractionated by a combination of various different J-IPLC techniques and capillary 
electrophoresis. Tumour an tigens arc being identified for their capacity to induce speci fic T cell 
responses in PBMC from the patient and/or healthy volunteers. Techniques of the matrLr 
assisted laser dismption I ionization time of flight mass spectrometry with post source dect1y 
011a~ysis combined wi th ladder sequencing approaches arc being developed for the elucidation 
of the peptide sequence. Pcptidcs th us identified can provide infom1ation on the antigenic 
structure of the tumour cells and pem1it to share the immune system's perception of the 
malignancy. More importantly, such peptides arc the basis for the deve lopment of tumour-
specific vacc ines for usc in cancer immunotherapy. 
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DOES A SMALL CELL VARIANT OF MYCOSIS FUNGOIDES EXIST7 
~sclenl p V M M Djcdercnl.....l.....I22m! S C J yan dcr Puuel L H PM Rademaker:fa 
• W A van Vlotf"J. 
Department of Dcnnatology , Palholog/ and Centre of Biostatistics], Un iversity Hospital Utrecht, The 
Nelhcrlands 
From S67..ary syndrome and pleimorphic cutaneous T cell lymphomas small cell variants have been 
described. Although the presence of oz1ly small lymphocytes without significant atypia has been 
described in some cases of mycosis fungoidcs (MF) the size of the cells or nuclei was not objcctivated. 
In a small percen1agc of the patient population of Utrecht with an otherwise clinical classic MF our 
pathologist hnd the impression that the infiltrate sometimes was composed of only small lymphocytes 
with hyperchromatic, deeply indented nuclei; small cell mycosis fungoides (SC.M_f} as seen with special 
fixa tion procedures (acid mercuric ch loride formalin fixation). We investigated whether this impression 
cou ld be objectivated using electronmicroscopy (EM). 14 patients with SC·MF were investigated. 10 
patients with n clinical and histologicn l MF (CL·MF) and 4 pa tients with various types or eczema (ECZ) 
served as control groups. We made 40·60 electron micrographs in each patient of the most dense part of 
the infiltrate always inc luding epidem1al MF cells. lltese were analysed with a computer equipment 
calculating the Nuclear Contour Index (NCI), Lhe mean PERDAS nuclear area (Perimeter ratio before 
and afler smoothing), the mean nuclear area, the p75 of the nuclear area and tJ1e percentage of cells 
larger than 30 ~tm1 , 
Statistical analysis revea led that the nuclear area of lympboid cells from patients with SC·MF and CL· 
MF differed significantly (mean nucle:n area: 17,62 vs. 23,15 11ml; p<0,02 and p75: 20,66 vs. 27,86 
pm2; p<O,O l ), The NCI of SC-MF and CL-MF were almost equal; 6,94 vs. 7,20; p""0,66.Thc nuc lear 
area ofSC-MF and ECZ did not di!Tcr significantly (17,62 vs. 18,96 Jlm1; p""0,29). 
We conclude that a smal\ ce\\ variant of MF indeed does exist and that it can be objcctivatcd by EM. 
1'11cse results might have diagnostic implicnlions in the patients with parapsoriasis en plaques where the 
pathologist could fail to diagnose mycosis fungoidcs. 
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MYCOSIS FUNGO! DES lN A CillLD: CASE REPORT 
A. Poletti M. Chiarantano~ C Yeller Fomasa~ S. Rosin P Gasparin N. Pcnncllj A. Pcscrico:. 
Institute of Pathology and Institute of Dermatology •, Un iversity of Padua, Italy 
We report a case of mycosis fungoides presenting in a chi ld , 9 years old, with no pruritic 
erythematous, scaling dermatit is on the abdominal region, with two greater plaques and severa l 
smaller in periumb il ical region, without other clinical manifestation (e .g. no 
\ymphoadcnopa\hy, hepatosplenomegaly). Her general health was good. Results of laboratory 
studies showed normal complete blood counts, biochemical, and liver function tests. There 
were no circulating SCzary ce lls at time of admission. Skin biopsy was performed on one 
greater lesion and histo logy showed infiltration on superficial derma by small lymphoid cells 
with hyperchromic nuclei , sometime with convolution, and indentation of the nuclear profile . 
These clements in restricted arcus infiltrate the basa l layer of the epidcm1is, configuring 
Pautricr- li kc microabsccsses. Immunohistochemica l studies revealed a T cel l phenotype of the 
majority of tJ1e lymphoid cell s, wi th predominncc of CD4+ cells in the intracpidcrmal 
compartimcnl. 
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ADULT T CELL LEUKAEMIA/LYMPHOMA 
M Setoyama K Katahira A. Tnnaka T Kanzaki 
Kagoshima U11iversity, Japan 
Adult T cell Jcukaemin!Jymphoma (A l'LL) is a malignant Jyrnphoproli ferative disorder which 
is caused by human T cell lymphotropic virus type I (BTLV-1). This disease commonly 
involves the skin as we ll as lhc peripheral blood and lymph nodes. Cutaneous involvement has 
been recognised in more than half of ATLL patients. Our university is located in the south-
western region of Japan where I-ITLV-1 is endemic. Over the past IS years we have coll ected 
118 cases of ATLL with cutaneous manifestations. All patients examined were positive for 
HTLV-1 antibodies. The male to female ratio was 1.9 : 1. The median age at first visit was 65 
years. According to the classi_fication of the clinical subtype of ATLL, 21 patients were 
classified as acute lype, 20 patients as chronic, 25 patients as lymphoma and 52 patients as 
smouldering. All patients exhibited skin lesions. Most patients showed indurated erythemas 
(39.4%), papules (16.5%) and nodules and tumors (3 1.2%) siml\ar of those occurring with 
CTCL. Some patients displayed unusual skin manifestations resemb ling those of other skin 
diseases. including drug erupt ions, viral eruptions, dyshidrotic eczema, pahnoplantar 
pustu losis, psoriasis, pa lmoplantar hypcrceratosis, ichthyosis, fo llicu li tis, alopecia, and purpura. 
Histo logicall y, individual cutaneous lesions displayed various degrees of tumor cell infiltration 
from the cpidcnnis (J>autricr's microabscess) to the subcutaneous adipose tissue. We report 
here the clinical and hi stological features of these cases as well as the statistical dnla. 
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PILOTROI'I C MYCOSIS FUNGOIDES PIU:SENTING AS AN ACNEIFORM 
ERUPTION. 
K. Pcritf M.C Fnn:noli1. M. Fnz io1 P. Donati1 S. ~himenti1 
Department .of Dcnnatology, University of L' Aqulia , lstituto San Ga ll icano2, Rome; Italy 
Pilotropic mycosis fungoides is a rare, recently described variunl of mycosis fungoidcs (MF) 
histologically characterised by rOniculotropic infiltrates of atypical T-lymphocytcs with sparing 
of the cpidennis. A 47-year-o ld woman presented with a 3·year hi story of comedones, 
microcysts and fo llicu lar plugs di sseminated over the face, trunk nod groins. The lesions were 
pruritic and partially connuen t in plaques. Tota l alopecia of the seulp and purtia l hair loss of the 
eyebrows as well as of the ax illae and groins were also present. Cerv ical, axillary nod inguinal 
lymph nodes were palpable. Histologic and immunophenotypical examination of skin biopsy 
specimens from the neck and trunk revea led perifoll icular and intrafollicular infiltrates of 
'atypical CD4+ T -lymphocytes without epidcrmotropism. Dilated .hair follicles filled wi th 
ccratinous plugs and fo ll icu lar cosinophiles were also observed. laboratory findings showed 
syderopcnic anaemia and an increased ratio ofCD4+/CD8+ lymphocytes (6 .75; n.v. 1-3). Gene 
rearrangement studies by polymerase chain reaction demonstrated a clonal umplification of the 
TCR:y. Staging of the patient (chest X-ray. ultrusounds of the liver and spleen and bone marrow 
biopsy) showed a non-specific in fi ltrate. Based on clin icopathological and molecular findings a 
diagnosis of pi lotropic MF was made. The patient was treated with ctrctinatc (40 mgldic) and 
interferon (3 x 106 ru three times a week) with good cl inicul response. TI1i s case highligh ts the 
broad spectrum of clinical presentations of MF which may cause diagnostic uncerta inty and 
result in delayed treatment. 
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CUTANEOUS CD4+ CD56+ CELL TUMORS: REI'ORT OF 6 CASES 
T. Petre lla S Dalnc E 'Ommine P. Joly L. A mould J Wechsler M. Brwot J Boso M r: 
Avril T Molina A Dcvitas 0 Lnmbcrt and the French Study Grour of Cutaneous 
Lymphomas 
Department of Pathology and Dennatology, Centre Hospitalo-Univcrsitaire, Dijon. France. 
'Ote authors report six cases of particular cutaneous tumors se lected from the registre of the 
French Cutaneous Lymphomas Study Group. ·n tc patients (2 males, 4 females) were aged 38 to 
84 years. They initially presented cutaneous nodules or infiltra tive papules. All but two, 
presented with regional lymph nodes. Staging were negative excepted one patien t with bone 
marrow involvement. His tological features were relevant with pleomorphic medium T cell 
lymphomn, but these ce lls exhibiting a distinguishing phenotype. They were positive for CD4, 
CD56 and also CD43. All other T cel l, and B ce ll markers were negative. 'l11c myclomonocytic 
markers were negative excep ted CD68 which was weakly posi ti ve in 3 cases. Others NK-cclls 
markers and CDJ4 were negative. PCR studies did not detect any B or T clonal rearrangement. 
All patients were treated successfully by polychcmotherupy, but 4 of them relapsed with bone 
marrow involvement (4/4) and leukaemia (3/4). ll1ey died in S to 24 months. ·n1e 2 remaining 
cases are ulivc, one is in cutaneous progression at 8 months and the other one is in remission at 
12 mon ths. 
The orig in of these cells is unclear. Despite expression of CD4 or CD56, we failed to 
demonstrate aT cell or NK-cc\1 origin. CD4 and CD56 arc not spccilic ofT or NK lineages. 
'Illcse two markers arc known to be expressed by monocytic ce lls. ' lllcsc 6 cases with other 
simi lar exceptional single cases reported, seem to represent a new entity developed from 
lymphoid or more likely myc lontonocytic precursor cells. 
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EFFECTIVENESS OF COI'/CllOI' REGIMENS IN THE TREATMENT OF l' IUMAI!Y 
CUTANEOUS LYM I' AOMAS : A CLINI CAL FOLLOW-UP STUDY OF HO l'ATIENTS 
M.G BcmcnPo M.T. Fjerro P Ouaglino P. Savoia A. Appjno 
Department of Medical and Surgical Specialities, Dcnnatologic Section, 1' 1 Dermatologic 
Clinic, University of Turin, Italy. 
'Inc efficacy of systemic polychcmolherapy in the treatment of primary cutuncous 8-cell 
lymphomas (CBCL) or T-ccl l lymphomas (CTCL) is still controversia l. In CBCL patients, 
polychemothcrapy is usua lly given in the presence of multiple cut:mcous lesions. Converse ly, it 
is usually administered to CTCL patients in the presence of advanced visceral disease or 
progressive cutaneous disease. 'lllc aim of this study wns to evi!lual'e the effectiveness of 
COP/CHOP regimes, in a series of 80 patients with cutaneous lymphoma (45 primary CBCL 
and 35 CTCL). 
In primary CBCL, the overall objective response rate (RR} was 98%, with nn 89% CR rate. 
Five-year DFS survival was 70%, with a 32% relapse-rotc. All relapses occurred in the COP 
treated group. No differences in RR or relapse-rate were found according to the histopathologic 
diagnosis. Patients with CBCL localised on their legs or diffuse to trunk and legs showed a 
higher relapse-rate (47% vs. 65%) than those with cutaneous lesions localised on the ir trunk or 
head. Five-year event- free survival was 97%. ln CTCL patients, the overall objective Rlt was 
40%, with u 23% CR rate and median response duration of 5.9 months. Mycos is fungoidcs 
patients showed a higher RR (8/17; 47%) than did SCzary syndrome patients (1/ 13; 8%). All the 
five patients with pleomorphic or immunoblastic primary C f CL achieved a short-lived CR 
(median survivu l: I 0 months). Our results confirm the good prognosis of primary CBCL and 
the cfficncy of polychemothrnpy according to COP/CHOP regimens. CI-IOP regimen is to be 
preferred to COP in us much as it reduces relapse ra tes. Conversely, there arc no indicutions for 
the usc of COP/CHOP regimens as first-line chemotherapy in CTCL patients. 
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T CELL RECEPTOR f PCR AND IMMUNPIIENOTYPING lN THE DIAGNOSIS OF 
CUT AN EO US T CELL LYMI'HOMAS 
W. Placek H. Audrihi M.Woidy!lo and A.Lukows~ 
Department of Dcnnntology, Medical University of Gdansk, Poland; ·Department of 
Dermatology, Medical faculty Charit6, Humboldt University Berlin, Germany 
1l1c diagnosis of cutaneous T cell lymphomas (CTCL) is performed by clinical examination, 
histology~ immunphcnotyping, ullrastructural electron microscopy and, presently, by PCR 
techniques also. 
We investigated paraffin embedded and frozen skin biopsy samples of suspcctrcd CTCL 
patients by histology, immunophenotyping and T cell rcccptor(TCR)y PCR. 
Immunophcnotyping was done with monoclonal antibodies for COl a, CDJ , Cp4, CDS, MTB 1, 
CD30, CD79n, CD45RO, and CD68 using the APAAP teclmique. For the PCR, iso lated DNA 
was amplified with consensus TCRy VI and J l/2 primer. The PCR products were separated on 
a heteroduplex temperature gradient gel electrophoresis including silver staining in order to 
discriminate monoclonal and polyclonnl TCR rearrangements. 25 cases of malignant 
lymphomas and one case of pscudolymphoma were preliminary diagnosed according to 
histology and clinical investigation. 18 samples from 15 patients showed the· typical histologic 
picture of Mf or Sezary Syndrome (SS) and were confim1cd by PCR as monoclonal T cell 
pro liferations. ln 3 patients the hi stology and immunphcnotyping indicated MF whereas the 
PCR demonstrated polyclona lity. The clinical course of the di sease in these Pat ients has been 
mild. In 2 patients with other CTCL monoclonal rearrangements occurcd. Because 
monoclonality WDS found by TCRy PCR continously during the observed course of di sease in 
all patients with advanced MF, SS or other CTCL, the method is a valuable tool in the 
diagnosis of CTCL. 
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EXTRACORPOREAL I'HOTOCIIEMOTHERAPY ASSOCIATED WITH ADJUVANT 
TREATMENT IN SEZARY SYNDROME 
L. Laroche V. Gallais A. Leon J . Baudclot M.Tod 
HOpital Aviccnne, Department of lmmuno-Dcrmatology, Blood bank and Pham1acy, 
University of Paris Xlll, Fmncc 
For the last 15 years, cxtracorporcal photochemothcrapy (ECP) has been used to treat various 
forms of cutaneous T cell lymphomas mostly as monotherapy. 
TI1e aim of our study was to eva luate the combination of r~djuvanl therapy with ECP in SCzary 
syndrome patients. Scqucntir~l addition of adjuvant therapy. defined as a modality not known to 
be consistently effective in SS, was admin istered to initial ECP alone in a group of 11 SS 
patients. It consisted of low-dose methotrexate (MTX), low-dose interferon (IFN), topical 
chemotherapy such as nitrogen mustard (HN2) followed by BCNU, and retinoids. Unlike 
MTX, lFN and rctinoids in combination with ECP which was unremarkable, addition of topical 
nitrogen musta rd led to 54% clinical remission and nomu1lization of hemato logical and 
immunological parameters in some patients. Topical BCNU combined with ECP induced a 
complete remission in 2/2 patients. 
Whether or not this effect is linked exclusively to HN2 or BCNU and ECP or previous ECP 
combined therapies remains to be determined. Rondomizcd trial s nrc needed to further define 
the best combination modality with ECP. 
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DNA STABILITY OF LYMPHOCYTES FROM PATIENTS WITH CTCL USING THE 
COMET ASSAY 
C. Wang M. Lund K. Bang K. Thestrup-Pcdersen 
The Department Dermatology, Marscl isborg Hospital. Aarhus C., Denmark 
DNA instability is found in many types of cancer cell s. We used the COMET assay to study 
both DNA stability and DNA repair mechanisms in lymphocytes from blood or skin ce ll lines 
in patients with CTCL. The COMET assay looks at the spreading of DNA during 
electrophoresis after n standardized domagc with X-ray or UVB. DNA repair is studied by 
incubating the lymphocytes for various periods of time following the damage. The degree of 
damage is meosu.rcd by image analysys. 
We have observed that both blood lymphocytes and T Lymphocytes from skin-derived cell 
lines of patients with C TCL had increased DNA instabi lkity and decreased DNA repair 
following damages induced by X-ray and UVB. Further investigations will look at eventual 
differences according to di sease stage. 
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CA 1'1LLARY LEAK SYNDROME REVEALING AT CELL LYMPHOMA 
L LAROCHE1 P CASASSUS1 J. WECHSLER' 
1-IOpi tal Avicennc1 and Henri Mondor2, Bobigny and Cr6tcil , France 
Capillary leak syndrome (CLS) is a rare and severe disorder with high morta lity. We rcpon a 
case of a 57-year-old man who had genera lized edema associa ted with a 12 kg weight gain. a 
non pruritic morbillifom1 rash, diiTuse arthralgia, myalgia and fever. No hypotension or pleural 
effus ion was observed. For 3 yea rs he had been in complete remission for 3 years for an 
angioimmunoblastic lymphadenopa thy type T ce ll lymphoma. No tumora l, cardiac or kidney 
etiology was found. Skin biopsy shOwed a moderate monomorphous perivascular infiltrate 
consist ing of small T l1elpcr lymphocytes with irregular nuclei. Loss of 2 pan T :mtigcns was 
observed and a TCRygcne rearrangement similar in blood and skin was detected. Done-marrow 
involvement was found . Polychcmothcrapy induced a transient comple te remission. 
This case is a typical example of CLS which consists of generalized erythematous edema 
associated with weight gain , fever, arthralgia and myalgia. ll1is clinical presentation resembles 
the idiopathic CLS described by Atkinson. Secondary CLS have been reported during growth 
factor treatment (IL2, GMCSF) rmd in association with hematologica l disorders. CLS 
associated with lymphoma has been described only three times. Skin biopsy was consistent 
with a T cell lymphoma associated with a major T clone at molecular level. CLS 
pathophysiology is poorly understood. Va rious factors modifying copillary pcnncability such 
ns VGEF and TNFa , LLI3, JL6, possibly produced by cutaneous tumor ce lls can be proposed. 
